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During the past few years, rationing has become an explicit feature in 
decisions concerning optimal delivery of health care services, and it 
poses difficult choices for health care providers and policymakers. 
Insurers and patients increasingly must balance the desire for access to 
every possible treatment against concerns about affordability. 
Cost-driven treatment decisions are an unavoidable reality for most 
patients.1 Apparently, however, another more pernicious type of 
rationing occurs in this country, and it does not depend on factors such 
as the likelihood of an optimal outcome, the comparative efficacy of 
different available treatment modalities, or even the ability to pay for 
care. Instead, a growing body of evidence suggests that race adversely 
affects the quantity and quality of health care provided to minority 
patients. Although no one has found widespread overt racism by 
providers, such inequities in the delivery of health care services pose 
serious problems.2 Ultimately, the medical establishment must face up 
to the reality that African American patients do not always receive equal 
treatment in the health care system. 
President Clinton's recent initiative to create an advisory panel to 
promote a dialogue about racial problems has generated mixed reactions 
from the public; some applauded the move, but others expressed 
skepticism that government could improve race relations.3 Much of the 
public debate about race relations has focused on employment and 
1. See generally David Orentlicher, Destructuring Disability: Rationing o/Health 
Care and Unfair Discrimination AgaillSt the Sick, 31 HARV. C.R.-C.L. L. REv. 49 
(1996). Some patients are confronted with cast-driven treatment decisions directly via 
high premiums, deductibles, and co-payments paid out-of-pocket. Others, whose 
employers provide health coverage, experience cost constraints indirectly when managed 
care organizations restrict treatment access or options. 
2. See Louis W. Sullivan, From the Secretary ofHealth and Human Services, 266 
JAMA 2674, 2674 (1991) ("I contend that there is clear, demonstrable, undeniable 
evidence of discrimination and racism in our health care system. For eXanIple, each year 
since 1984, while the health status of the general population has increased, black health 
status has actually declined."); see also David R. WillianIS et al., The Concept ofRace 
and Health Status in America, 109 PUB. HEALTH REp. 26, 26 (1994) (noting that, despite 
signiticant medical progress over the course of the twentieth century, African Americans 
"continue to bear a higher burden of death, disease, and disability."). 
3. See Steven A. Holmes, Many Uncertain About President's Racial Effort, N.Y. 
TIMES, June 16, 1997, at Bl. At a meeting of the race advisory panel, President Clinton 
urged the panel to develop a "compendium" of successful approaches to fostering racial 
harmony that have been used in different locations, and the President suggested that the 
panel publish these successful efforts so that they can be utilized elsewhere. See Steven 
A. Holmes, President Nudges His Race Panel to Take Action, N.Y. TIMEs, Oct. 1, 1997, 
atA3. 
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university admissions. The role that conscious or unconscious racial bias 
may play in the health care context has, by comparison, attracted 
comparatively little public attention, t.lmugh a growing number of studies 
appearing in the medical literature explicitly consider the race of patients 
as one potentially relevant variable. This Article attempts to frame the 
debate about racial justice in the delivery of health care services, first by 
surveying several examples of such disparities, and then by connecting 
these examples with the existing legal literature concerning the range of 
possible remedies for discrimination. In a society that remains 
pessimistic about race relations,4 the equitable provision of medical 
services represents one area that demands prompt and serious attention. 
In general, the problem of inadequate access to health care for 
uninsured Americans contributes significantly to the problem of disparate 
health status among the races. This Article focuses only on the role of 
conscious and unconscious racial bias in the delivery of care and does 
not begin to address the larger issue of inadequate access to care at the 
outset. Improving access to health care for minorities will undoubtedly 
have a positive effect on these groups' overall health status; however, to 
the extent that racial bias in the delivery of care exists apart from 
problems of inadequate access, the disparity in health status between 
whites and African Americans will no doubt continue.5 
Part II of this Article describes racial disparities in a variety of health 
care contexts including the utilization of Medicare services, the selection 
of recipients for cadaveric organ transplantation, access to drug therapy, 
institutionalization for mental illness, and the representation of racial and 
ethnic minority groups in clinical research. Part II closes with a 
4. A recent Gallup poll revealed that 55% ofAmericans believe that race relations 
will "always be a problem" in the United States, while only 42% believe that a solution 
will eventually be reached. College-educated African Americans demonstrated the 
greatest level of pessimism about race relations; 65% of this group said that problems 
between the races would always exist. See Steven A. Holmes, New Survey Shows 
Americans Pessimistic on Race Relations, N.Y. TIMEs, June 11, 1997, at A4. 
5. Much of the discussion in this Article focuses on health disputes between 
whites and African-Americans, and only to a lesser extent on disparities between whites 
and other races. Some critical race theorists have criticized the application of 
conclusions about relations between whites and African-Americans to white relations 
with other racial minority groups. See, e.g., Juan F. Perea, The BlacklWhite Binary 
Paradigm of Race: The "Normal Science" of American Racial Thought, 85 CAL. L. 
REv. 1213 (1997). Many of the proposed approaches to the problem of racial bias in 
health care discussed within this Article implicitly or explicitly reject a "one size fits all" 
approach to treatment decisions and communication issues in health care. 
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discussion of some of the problems inherent in measuring the degree of 
the disparate care problem and in isolating and evaluating the role that 
race plays in health care decisionmaking. Part III suggests potential 
solutions to the problem of disparate medical care for racial minorities, 
including possible constitutional and statutory remedies for past victims 
of disparate treatment, avenues for governmental enforcement of policies 
prohibiting discrimination, and other approaches for avoiding future 
inequalities in the delivery of medical services. This Article concludes 
that prospective approaches, such as education and regulatory responses 
to patterns of disparate care, provide the most promising avenues for 
addressing this troubling problem. 
II. EXAMPLES OF RACIAL DISPARITIES IN HEALTH CARE DELIVERY 
Examples of racial disparities in health care delivery abound. 
Differences in the care delivered to patients span a wide range of health 
services, from organ transplantation to sophisticated coronary care to 
basic preventive care. Overall, the gap in health status between the 
African American population and the white population continues to 
widen.6 The following examples illustrate the magnitude of the 
problem, as well as the complexities inherent in evaluating the role that 
race plays in decisions to provide medical treatment. 
A. Provision of Medicare Services 
A study recently published by a team of investigators affIliated with 
the Health Care Financing Administration (HCFA) presents startling 
evidence of racial inequities in the delivery of health services.7 
Although previous studies have examined the utilization of health 
6. Fonner Secretary of Health and Human Services Louis W. Sullivan has 
observed: 
[E]ach year since 1984, while the health status of the general population has 
increased, black health status has actually declined. This decline is not in one 
or two health categories; it is across the board, from an infant mortality rate 
for blacks that is double that for whites to a life expectancy for black 
Americans that is 6 years less than that for white Americans. 
Sullivan, supra note 2, at 2674; see also Durado D. Brooks et al., Medical Apartheid, 
266 JAMA 2746, 2746-48 (1991) (describing the "wide disparity in ... preventable 
disease incidence, and life expectancy between white citizens and people of color" in the 
United States and South Africa, and discussing several models of health care delivery 
designed to improve equality of access to care). 
7. See Marian E. Gornick et al., Effects ofRace and Income on Mortality and Use 
of Services Among Medicare Beneficiaries, 335 NEW ENG. J. MED. 791 (1996). The 
authors note, however, that the opinions expressed in their article do not necessarily 
reflect those of HCFA. See id. at 798. 
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services among different racial groups, they often used race as a 
surrogate for socioeconomic status; thus, these studies frequently 
attributed differences in the quality and quantity of care afforded to 
minority patients to disparities in income.8 The HCFA study represents 
one of the first attempts to control for income among different popula­
tions, allowing the investigators to identify variations in the utilization 
of health care services based on race alone.9 
The HCFA investigators used Medicare administrative data from 1993 
covering more than twenty-six million beneficiaries, combined with 
Census data on estimated household income, to determine whether and 
to what extent race and income affect the utilization of health care 
services and mortality.10 In addition to overall mortality rates, the 
investigators focused on four categories of health services: first, visits 
to physicians for ambulatory care and hospital discharges; second, 
hospitalizations for ischemic heart disease, coronary-artery bypass 
surgery, and a type of coronary angioplasty; third, mammography (an 
elective Medicare service) and hip-fracture repair (a non-elective 
Medicare service); and, fourth, the amputation of a lower limb and 
bilateral orchiectomy. 11 
The data identified significant differences in mortality rates and in 
rates of utilization of health care services between white and African 
American patients. Among the HCFA study's findings, African 
American men were 19% more likely to die than white men (after 
adjusting for age and gender only). Mter adjusting for income, the ratio 
did not change dramatically; African American men were still 16% more 
likely to die than white men; African American women were 16% more 
8. See, e.g., Robert A. Hahn & Donna F. Stroup, Race and Ethnicity in Public 
Health Surveillance, 109 PUB. HEALTH REp. 7 (1994); Kenneth C. Goldberg et aI., 
Racial and Community Factors Influencing Coronary Artery Bypass Graft Surgery for 
All 1986 Medicare Patients, 267 JAMA 1473 (1992) (finding disparities in income to 
be an important factor in the differences in the rates of coronary artery bypass grafting 
between African American and white Medicare patients). 
9. See Gornick et al., supra note 7, at 792. 
10. An editorial accompanying the study suggests a pair of methodological 
weaknesses: the investigators relied solely on Medicare administrative data because they 
lacked access to medical records, and they used aggregated rather than individual income 
data. See H. Jack Geiger, Editorial, Race and Health Care-An American Dilemma?, 
335 NEW ENG. J. MED. 815, 815-16 (1996). 
11. See Gornick et al., supra note 7, at 792. Such amputations are frequently 
associated with complications of diabetes. Bilateral orchiectomy involves the surgical 
removal of the testicles to treat metastatic prostate cancer. 
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likely to die than white women (adjusting for income made no difference 
in this category). African American women were 25% less likely to 
have mammograms than white women, and African American patients 
of both sexes were 7% less likely to visit physicians for ambulatory 
care.12 
The data also suggested a tendency on the part of health care providers 
to pursue less aggressive therapies for African American patients who 
did seek medical care. Certain types of procedures were performed less 
frequently on African American patients than on white patients, even 
after income adjustment. For example, white patients were at least twice 
as likely to undergo a type of coronary angioplasty, coronary-artery 
bypass surgery,13 and hip repair surgery. 14 In contrast, other proce­
dures were performed more frequently among African American patients. 
After adjusting for income, African American patients were over three 
times more likely than white patients to have a partial or total amputa­
12. See id. at 797 tb1.2. 
13. Other studies also have examined racial variations in the use of sophisticated 
coronary procedures. In one recent study, researchers at Duke University compared a 
population of over 12,000 patients with coronary disease, 10.3% of whom were African 
Americans. The study calculated rates of angioplasty and bypass surgery, with and 
without adjusting for severity of the disease and related factors. Taking these factors 
into account, African Americans were 13% less likely than white patients to undergo 
angioplasty and 32% less likely to have bypass surgery. See Eric D. Peterson et al., 
Racial Variation in the Use of Coronary-Revascularization Procedures-Are the 
Differences Real? Do They Matter?, 336 NEW ENG. J. MED. 480 (1997). The 
significant variation in rates of angioplasty is particularly disturbing because, as the study 
authors point out, the differences did not result from variables such as disease severity, 
co-existing illnesses, or even varying rates of access to subspecialty care. See id. at 484. 
The study authors also noted that "the patient's (or the physician's) preferences for 
particular cardiac interventions may differ according to race. The decision to undergo 
cardiac intervention is a complex one and can be influenced by the patient's symptoms, 
the perceived risks and benefits of the procedure, and other factors, such as one's trust 
in medical approaches involving advanced forms of technology. Because these 
preferences can alter the final therapeutic decision in many instances, physician-patient 
interactions become key to understanding practice patterns." See id.; see also Earl Ford 
et aI., Coronary Arteriography and Coronary Bypass Survey among Whites and Other 
Racial Groups Relative to Hospital-based Incidence Rates for Coronary Artery Disease, 
79 AM. 1. PUB. HEALTH 437, 437-39 (1989) (noting that, among patients discharged 
from hospitals with a diagnosis of anterior myocardial infarction, African American men 
had a rate of this condition that was three-fourths the rate for white men, but that 
African American men were only half as likely to undergo angiography and one-third 
as likely to have bypass surgery as white male patients, even where other factors 
indicated that the severity of the illness between the groups of patients was similar at the 
time of admission). 
14. See Gornick et al., supra note 7, at 797. The authors concluded, however, that, 
with regard to hip fracture repair and other non-elective procedures, the rates did not 
suggest any racial inconsistencies. Because osteoporosis in the femur is 2.4 times more 
prevalent among white women than African American women over the age of 50, no 
real disparity exists. See id. at 798. 
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tion of the leg, and they were more than twice as likely to undergo 
bilateral orchiectomy as a treatment for prostate cancer. IS Significantly, 
in most of h~ese comparisons, adjustments for income dLffeIentialsdid 
little to diminish the racial disparities. 16 The greatest effects of the 
adjustment for income occurred in the figures for mammography and 
visits to physicians for ambulatory care. For example, among the least 
affluent African American women, the mammography rate was 39% 
lower than among the most affluent African American women.17 
Of course, differences in access to, or the utilization of, preventive 
care over a patient's lifetime may account for some of the observed< 
disparities in mortality rates and choice of treatment; once patients 
become eligible for Medicare at age 65, these long-developing differenc­
es in health status may be irreversible. The data also may simply reflect 
differences in the relative health status of the patients in the two groups 
arising from factors unrelated to differences in access to care. 18 The 
15. See id. at 797 tb1.2. Diabetes is only 1.7 times as prevalent in elderly African 
American patients as in white patients, which suggests that the difference in rates of 
amputation of a lower limb is not completely explained by differences in the prevalence 
of diabetes. See id. at 791. As with the data on hip fracture repair, the data on bilateral 
orchiectomy may suggest a disparity that does not really exist, because African American 
men have 2.2 times the rate of metastatic prostate cancer as white men. See id. at 792. 
However, other troubling disparities, such as lower rates of access to primary and 
preventive care among African Americans, may contribute to the differing rates of this 
advanced form of prostate cancer. See Scott A. Optenberg et al., Race, Treatment, and 
Long-Tenn Survival From Prostate Cancer in an Equal-Access Medical Care Delivery 
System, 274 JAMA 1599, 1604-05 (1995) (concluding that, after adjusting for stage of 
disease, African American and white patients receiving equal medical treatment and 
exhibited similar survival rates for prostate cancer). 
16. See Gornick et al., supra note 7, at 791, 797 tb1.2. After adjusting the 
mortality and health services utilization rates for income-related differences, the 
investigators found that racial differences diminished somewhat, but that the overall 
effect of the income adjustment was relatively insignificant. 
17. See id. at 794-95. 
18. The authors of the HCFA study suggested that a variety of factors, such as 
educational, cultural, and behavioral variables, differences in supplementary insurance, 
and the availability of services, may contribute to racial disparities in health care. See 
id. at 798; see also AMA Council on Ethical and Judicial Affairs, Black-White 
Disparities in Health Care, 263 JAMA 2344, 2344 (1990) (noting that African 
Americans are more likely to require health care but less likely to receive it); Jan 
Blustein & Beth C. Weitzman, Access to Hospitals with High-Technology Cardiac 
Services, 85 AM. J. PUB. HEALTH 345, 346-50 (1995) (discussing the relative scarcity 
of high-technology health care facilities in predominantly African American neighbor­
hoods, and noting that African American patients may be less likely to travel to such 
facilities to receive high-quality care). 
141 
data do not by themselves indicate that physicians or insurers provide 
suboptimal medical care to minority patients.19 
Even so, because the studied population shares a common insurer 
(Medicare), and thus enjoys uniformity of coverage for the services 
analyzed, the conclusions of the HCFA study deserve serious consider­
ation. This lack of an "insurance discrimination" factor (whereby 
under-insurance may account for observed treatment differences), 
together with the adjustment for income among the white and African 
American patients studied, strongly underscores the significance of the 
findings. The HCFA study clearly demonstrates that equal health 
insurance by itself does not ensure equal care. 
B. Allocation of Organs for Transplantation 
Racial inequities appear in a variety of other health care contexts. 
Recent statistics suggest some disparities in the rationing of expensive, 
lifesaving procedures and technology. In the area of organ transplanta­
tion, for example, demand far exceeds supply,20 and the debate 
continues about how best to distribute organs available for transplant.21 
In 1987, Congress created the Organ Procurement and Transplantation 
Network (OPTN).22 The United Network for Organ Sharing (UNOS), 
a private non-profit organization, operates OPTN under contract with the 
federal government, coordinating procurement and allocation functions, 
19. The study reported only aggregated data. Disaggregating the data may reveal 
additional useful information. For example, if the rates of usage remain consistent 
across doctors and institutions, this would suggest a systemic problem. However, if 
more pronounced treatment disparities appear at certain institutions or in certain regions 
of the country, the possibility of conscious discrimination at some facilities becomes 
more compelling. 
20. See Phyllis Coleman, "Brother Can You Spare a Liver?" Five Ways to 
Increase Organ Donation, 31 VAL. U. L. REv. 1, 14-25 (1996) (discussing various 
proposals to increase rates of organ donation). 
21. In 1996, over 34,000 patients in the United States were waiting for a kidney. 
See Testimony ofCass Franklin, M.D., DHHS Liver Allocation Hearings, Dec. 10, 1966, 
(visited April 16, 1998) <www.unos.org> [hereinafter Franklin Testimony]. Approximate­
ly one-third of patients waiting for a heart or liver transplant die before an organ 
becomes available, and the number of actual donors is significantly lower than the source 
potential. See Raja B. Khauli, Issues and Controversies Surrounding Organ Donation 
alld Trallsplallfation: The Need for Laws That Ensure Equity and Optimal Utility of a 
Scarce Resource, 27 SUFFOLK U. L. REv. 1225, 1225-26 (1993). Federal law prohibits 
the selling of organs or tissue. See 42 U.S.C. § 274(e) (1994). 
22. See National Organ Transplant Act, Pub. L. No. 98-507, 98 Stat. 2339 (1987) 
(codified at 42 U.S.C. §§ 273-74 (1994)). 
142 
[VOL. 35: 135, 1998] 	 Racial Disparities 
SAN DIEGO LAW REVIEW 
and UNOS also works to develop equitable policies for organ distribu­
tion.23 
For a variety of reasons, AfriCfu'l American patients wait longer to 
obtain kidney and other organ transplants than white patients.24 In part, 
organ donation rates by African Americans have lagged, though 
donations among minority groups recently have increased.25 Whites 
continue to account for most organ donations, and this limits the number 
of organs available for minorities where immunologic matching is 
deemed essentia1.26 In addition, demand for transplants may be higher 
for racial minorities. For instance, African Americans constitute 12% of 
the population in the United States but account for 34% of persons 
suffering from end stage renal disease (ESRD).27 The confluence of 
these supply and demand factors results in longer waiting times for racial 
minorities; African Americans recently accounted for more than 
one-third of patients on the waiting list to receive kidneys.28 
Before the allocation process begins, physicians must first evaluate 
potential transplant candidates to determine whether they meet medical 
23. See Organ Procurement and Transplantation Network, 42 C.F.R. pt. 121 (1998). 
In order to guarantee that transplant centers comply with UNOS policies, Congress made 
Medicare and Medicaid reimbursement dependent upon membership in the OPTN and 
adherence to UNOS rules. See 42 U.S.C. § 1320b-8(a)(1)(B) (1994). 
24. See Khauli, supra note 21, at 1231 & n.30; see also Ian Ayres et al., Unequal 
Racial Access to Kidney Transplantation, 46 V AND. L. REv. 805 (1993) (discussing 
reasons for disparate access to kidney transplantation among different racial groups). 
25. See Stuart Auerbach, Organ Donations by Minorities Rise, WASH. POST, Feb. 
27, 1996, Health News, at 7 (noting that African Americans accounted for 11.5% of the 
5100 organs that were donated in 1994, which represented only slightly less than this 
group's 12.1% share of the population). 
26. See Khauli, supra note 21, at 1231-32; see also Fred P. Sanfilippo et al., 
Factors Affecting the Waiting Time of Cadaveric Kidney Transplant Candidates in the 
United States, 267 JAMA 247,251 (1992) (noting that differences in antigen distribution 
between white and African American patients "result in a biologic disadvantage to" the 
latter). 
27. See Robert S. Gaston et al., Racial Equity in Renal Transplantation, 270 
JAMA 1352, 1354 (1993). See also Franklin Testimony, supra note 21. Dr. Franklin 
noted that, of the 34,000 patients waiting for a kidney, 34% are African Americans, 9% 
are Hispanic, and 5% are Asian, and explained that, with regard to transplantation of 
organs other than kidneys, allocation inequities do not appear to pose a problem, but 
race-related concerns exist nonetheless. For example, because minorities historically 
tend to rely disproportionately on Medicaid for health care, and because state Medicaid 
program funding for such transplants varies widely, many Medicaid recipients who 
cannot leave their home states to seek a transplant elsewhere are forced to do without. 
See id. 
28. See Khauli, supra note 21, at 1231-32. 
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and other criteria to be placed on a waiting list. The potential for 
racially-biased decisionmaking exists at this stage, as much as at the 
organ allocation stage of the transplant process.29 Although the UNOS 
allocation policies do not explicitly consider race, the emphasis on 
obtaining better results through close or exact tissue-matching helps to 
explain some of the disparities. Generally, donated organs are allocated 
to medically qualified candidates,30 using a point system that takes into 
account patient proximity. The current policies also permit variances to 
the point system and allow alternative local organ distribution units to 
be established subject to OPTN approval.31 For kidneys, livers, and 
pancreata, potential recipients are ranked with points allocated to reflect 
different criteria, including blood type, histocompatibility, sensitivity of 
the patient to transplantation, degree of urgency, and waiting time. 
29. In the southeastern United States, physicians refer African American patients 
for transplantation less frequently at the outset than white patients. See J. Michael 
Soucie et aI., Race and Sex Differences in the Identification of Candidates for Renal 
Transplantation, 19 AM. J. KIDNEY DISEASES 414 (1992); see also Organ Procurement 
and Transplantation Network,59 Fed. Reg. 46,482-86 (1994) (noting that current rules 
and proposed rules permit patients to be listed at multiple transplant centers, and inviting 
public comment on this policy); Sanfilippo et aI., supra note 26, at 251 (concluding that 
patients with the financial resources to be listed at two or three transplantation centers 
have significantly shorter waiting times, and that multiple center listing discriminates 
against socioeconomically disadvantages transplant candidates). At the outset, physicians 
must decide whether to list a patient for transplant: 
Experience indicates that if physicians are forced to choose among people in 
the allocation of scarce medical resources, they will choose people most like 
themselves and exclude those whom they deem ''unworthy.'' Given that 
prosperous, white physicians probably do most of the selecting, there is a risk 
that the poor and minorities will have less chance of being selected than 
middle-class whites. 
Devl'iopments in the Law-Medical Technology and the Law, 103 HARv. L. REv. 1519, 
1630-31, 1636-37 (1990) [hereinafter Medical Technology and the Law) (citations 
omitted). 
30. The health of the transplant patient, and the presence of other co-morbid 
factors besides the diseased organ itself, strongly correlate to the rate of transplantation. 
In a study analyzing the effect of co-morbid and sociodemographic factors on the rates 
of cadaveric kidney transplantation, the investigators noted that certain types of cardiac 
disease, diabetes, and other disease conditions were strongly associated with lower 
transplantation rates. See Daniel S. Gaylin et al., The Impact of Comorbid and 
Sociodemographic Factors on Access to Renal Transplantation, 269 JAMA 603, 607 
(1993). However, the investigators also noted that the effects of sociodemographic 
factors were not mitigated by adjusting for co-morbid factors. U[T]his study demon­
strates that sociodemographic indicators ., . are important predictors of access to 
transplantation: female sex, older age, race other than white, and low income are each 
associated with lower transplantation rates. These [mdings cannot be explained away 
as 'surrogate' effects related to case mix." Id. at 608. 
31. See Organ Procurement and Transplantation Network, 59 Fed. Reg. at 46,482, 
46,486-87. For example, alternative local organ distribution units might be permitted to 
develop interregional or intraregional organ sharing arrangements. See id. 
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In the case of kidney transplantation, UNOS has developed a 
prioritization system that relies heavily on human leukocyte antigen 
(HLA) matching t{)determine which patients will receive kidneys as they 
become available. This policy establishes point values for the quality of 
antigen matches, strongly favoring a perfect match.32 The current 
system significantly curtails access by African Americans to cadaveric 
kidneys because the likelihood of a perfect lILA match is very low when 
matching white donors with African American recipients.33 The recent 
increase in African American donors will ameliorate this problem 
somewhat, but, as noted above, African Americans constitute a 
disproportionately large percentage ofESRD patients awaiting transplant. 
Increased kidney donation rates among minorities will not fully meet the 
needs of the African American patients at any time in the near future. 
Some physicians and medical ethicists have expressed concerns about 
the criteria used to determine which patients will receive organs for 
transplantation. In particular, the emphasis on tissue matching for 
kidney allocation has attracted significant criticism. The preference for 
a perfect antigen match in kidney transplantation appears unnecessary in 
this era of highly efficacious anti-rejection drugs such as cyc1osporine.34 
Physicians who question the heavy emphasis on perfect lILA matching 
suggest that the relatively small gains in successful outcomes do not 
justify the disparate impact of such policies on African American 
transplant candidates. On the other hand, a pure equity-based system 
(such as first-come, first-served) ignores other factors that will signifi­
cantly impact transplant outcomes.35 One group of commentators argue 
32. See id. 
33. See Gaston et al., supra note 27, at 1353 (noting that of six-antigen-matched 
recipients, initial reports documented fewer than 2% as African American, and that 
UNOS data confirms that African American patients received six-antigen-matched 
kidneys at one-tenth the rate of white patients). 
34. See id. at 1354. But see Steve Takemoto et al., Equitable Allocation of 
RIA-Compatible Kidneys for Local Pools and for Minorities, 331 NEW ENG. J. MEn. 
760, 760 (1994) (noting that perfect six-antigen-matched kidneys have a significantly 
higher projected survival rate-20 years for 50% of those grafts still functioning at one 
year, compared to 6 years for "the average transplanted kidney"). 
35. See Gaston et al., supra note 27, at 1354 (discussing the tension between 
equity and efficiency, and the flexibility of the term "medical criteria"). Commentators 
have observed: 
The allocation of organs on a first-come, first-served basis is untenable for 
practical reasons of immune sensitization and blood group compatibility. 
Moreover, consideration of equitable access without anticipated outcome may 
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that the emphasis on Ill..A matching unjustly disfavors interracial 
transplantation, noting that white dialysis patients are more than twice 
as likely as African American patients to receive a kidney allograft.36 
They contend that enhanced transplant survival for perfectly matched 
kidneys does not necessarily outweigh other factors relevant to the 
selection process,37 such as age and waiting time, and they suggest 
explicitly offsetting the racial disparities that result from the HLA 
matching system by, for instance, awarding points to African Americans 
to compensate for points accumulated by whites on the basis of HLA 
matching.38 
Although successful transplantation obviously represents the primary 
goal, the federal government directed OPTN to allocate organs "equita­
bly among transplant patients" and according to "established medical 
criteria.'>39 An overemphasis on improving outcomes does not promote 
equitable allocation, but sometimes makes financial sense, as long as the 
transplanted kidney survives for at least five years. The costs associated 
with preserving and transporting perfectly matched kidneys to more 
distant locations may outweigh the medical costs saved through 
improved graft survival (by avoiding the need for retransplantation or 
return to dialysis).40 However, some investigators have concluded that 
a system that combines partial matching with a regional hierarchical 
approach may prove to be more cost effective, in addition to reducing 
the disparate impact on minority transplant candidates created by the 
cun·ent preference for perfect matches.41 
have an overall negative impact for all patients waiting for transplantation if 
the result is an increase in the number of organs lost to rejection or 
nonfunction. 
Sanfilippo et aI., supra note 26, at 252. 
36. See Gaston et aI., supra note 27, at 1352 (citing statistics of 8.3% for white 
patients versus 3.9% for African Americans).. At the University of Alabama at 
Birmingham, which has a waiting list for kidney transplantation that is 65% African 
American, only one out of every 33 kidneys received as part of the perfect antigen match 
program has been slated for an African American patient. See id .. at 1353 .. 
37. See id. at 1354 (noting that, although a clear correlation exists between HLA 
match and outcome in transplantation from living donors, the benefits of a perfect HLA 
match in cadaveric transplants is less clear). 
38. See id. at 1355. But see Takemoto et al., supra note 34, at 763 (objecting to 
such proposals because giving points at the outset based on skin color or ancestry is 
equally unjust for others who do not qualify). 
39. See 42 U.S.C. § 274(b)(2)(A)(ii), (D) (1994).. 
40. See David W. Gjertson et aI., National Allocation of Cadaveric Kidneys by 
HLA Matching, 324 NEW ENG. J. MED. 1032, 1032-36 (1991); see also Takemoto et al., 
supra note 34, at 760 (noting that only when a kidney survives more than five years is 
transplantation less expensive than maintenance dialysis). 
41. See Takemoto et aI., supra note 34, at 760,763 (proposing a matching system 
that awards points for waiting time and for matches among the widely shared "HLA 
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The conflict between concerns about transplant efficacy and distribu­
tive justice continues in the area of organ transplantation. In 1996, the 
United States Public Health Service (PHS) announced a public forum to 
discuss proposed changes to policies for the allocation of livers and 
patient listing criteria for liver, kidney, and kidney/pancreas trans­
plants.42 And under rules proposed in 1994, the OPTN would develop 
policies based on a variety of criteria to dictate the organ allocation 
process.43 In addition to considering established medical criteria and 
length of time on the national waiting list, OPTN would be charged with 
the task of developing policies that more effectively take into account 
potential recipients whose immune system sensitization makes it difficult 
for them to receive organs, and it would thereby seek to minimize 
wastage of organs.44 The proposed rules have not, however, been 
finalized.45 
C. Access to Prescription Drug Therapy 
A review of the medical literature reaffIrms what the overall disparity 
in health status between white and minority individuals already suggests: 
race-related differences abound in access to and the utilization of a wide 
detenninants" only, and concluding that such a system would obviate the need for much 
national kidney sharing while simultaneously improving equity of allocation and 
preserving maximal long-term kidney graft function). 
42. See Meeting Notice, 61 Fed. Reg. 46,658 (1996); see also Organ Procurement 
and Transplantation Network, 61 Fed. Reg. 58,158 (1996) (soliciting additional 
comments on the allocation of human livers). UNOS organ allocation policies have been 
scrutinized by the General Accounting Office as well. See, e.g., GENERAL ACCOUNTING 
OFFICE, ORGAN TRANSPLANTS: INCREASED EFFORT NEEDED TO BOOST SUPPLY AND 
ENSURE EQUITABLE DISTRIBUTION OF ORGANS (1993). 
43. See Organ Procurement and Transplantation Network, 59 Fed. Reg. 46,482 
(1994) (proposing rules for listing transplant candidates on a nationwide computer 
network, for allocating organs, and for recordkeeping and reporting by organ 
procurement organizations and transplant hospitals). 
44. See id. at 46,497. In discussing the proposal, the PHS acknowledged that 
organ allocation poses difficult issues: 
For example, efforts to promote service to the sickest patients first versus those 
likely to survive the longest may conflict Similarly, some policies intended 
to maximize transplant outcomes and based on sound scientific data may have 
adverse implications for one ethnic group in particular, or for residents of 
particular geographic areas. 
[d. at 46,486. 
45. See 62 Fed. Reg. 21,662, 21,707 (1997) (Semi-Annual Unified Regulatory 
Agenda) (providing no estimated finalization date). 
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variety of therapies, treatments, medications, and general preventive care. 
The following examples dealing with access to prescription drug therapy 
help to illustrate further the dimensions of the problem. 
One study examined prescription drug therapy for mv disease among 
patients presenting themselves for treatment at an urban AIDS clinic 
over almost a three-year period.46 Using a set of medical eligibility 
criteria based on the patients' CD4+ cell counts at the time of referral to 
the clinic, the investigators found that African American patients were 
significantly less likely than white patients to have received antiretroviral 
therapy (63% of eligible white patients compared with only 48% of 
African American patients) or prophylactic therapy for Pneumocystis 
carinii pneumonia (82% of eligible white patients compared with 58% 
of eligible African American patients).47 The study also examined 
these rates of drug utilization when adjusted for other patient factors 
such as income, insurance status, mode of mv transmission, and place 
of residence. The results revealed that the addition of these variables to 
the equation failed to explain the racial disparity in rates of drug 
therapy.48 Because of the barriers to care for young African Americans 
at risk for mv,49 and an apparent pattern of disparate treatment for 
those who have contracted the disease, the study's authors recommended 
a plan of early intervention using "culturally appropriate" methods and 
suggested that a community-based partnership between an academic 
medical center and the high-risk population might be effective.50 
Although relatively little data exists on the relationship between race 
and the use of prescription medications for children, one recent study 
found that, while approximately 79% of white children between the ages 
of one and five received a prescription medication when visiting a 
doctor, only 63% of African American children received prescriptions. 
For patients aged six to seventeen, 66% of white children received 
46. See Richard D. Moore et aI., Racial Differences in the Use ofDrug Therapy 
for HIV Disease in an Urban Community, 330 NEW ENG. J. MEO. 763 (1994). 
47. See id. at 764. 
48. See id. at 764, 766 tbI.4. 
49. The authors noted that African Americans, especially young inner-city males, 
"have historically neither sought nor had access to medical care, particularly preventive 
medical care . . . . [and] are the group least likely to have a regular primary care 
physician." Id. at 767. 
50. See id. at 767 (suggesting that community churches provide one avenue for 
interacting with the at-risk population and concluding that the increasing shift of HIV 
disease to poor urban communities "underscores the need for effective intervention to 
improve access to care"); see also Merrill Singer, Confronting the AIDS Epidemic 
Among IV Drug Users: Does Ethnic Culture Matter?, 3 AIDS Eoue. & PREVENTION 
258 (1991). 
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prescriptions compared with 52% of African American children.51 
Once it factored in additional predisposing variables, such as the child's 
age and the education level of the child's mother, and enabling variables, 
such as health insurance coverage and poverty status, the study 
concluded that, of children who visited the doctor at least once, African 
American children were approximately half as likely as white children 
to receive a prescription medication.52 
As with several of the other examples described above, the racial 
differences in rates of prescription medication access persisted even after 
adjusting for major variables-the study's author theorized that at least 
part of this variation may result from language barriers, cultural biases, 
or discrimination in treatment of minority patients.53 The significance 
of these study results is not entirely clear. Although the investigators 
attempted to control for variables such as insurance coverage, such 
studies cannot adequately capture the nuances of the prescribing decision 
process. For example, some of the variations in rates of prescribing may 
arise from the physician's misperceptions about the patient's insurance 
coverage for prescription drugs. Even if insurance coverage is factored 
into the equation, the prescriber may still make incorrect assumptions 
about Mrican American patients' likelihood of having prescription drug 
coverage, particularly if doctor and patient do not explicitly discuss 
insurance coverage during the consultation. And, for a variety of 
reasons, the parents of white children may be more insistent about 
obtaining a prescription to treat their children's illnesses. Furthermore, 
over-prescribing of drugs (particularly antibiotics) to treat simple 
childhood illnesses may cause long-term problems for individual patients 
and patient populations. Thus, although the study's conclusions point 
out an example of disparate care, the cause and significance of this 
disparity remains difficult to pinpoint. In fact, the reasons for individual 
prescribing decisions no doubt vary a great deal and may have no racial 
component once other explanations for these decisions receive consider­
51. See Beth A. Hahn, Children's Health: Racial and Ethnic Differences in the Use 
of Prescription Medications, 95 PEDIATRICS 727, 729 tbl.1 (1995). 
52. See id. at 730 tb1.2. 
53. See id. at 731. After controlling for the number of physician visits, need 
variables (i.e., the health status of the child, the number of bed-days, and the number of 
reduced activity days), predisposing variables, and enabling variables, the study found 
that African American children were approximately 70% as likely as white children to 
receive a prescription medication. Id. at 730 tb1.2. 
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ation. Additional studies, designed to capture these variables more 
effectively, may help in the formulation of policies to address unex­
plained patterns of disparate prescribing. 
D. Diagnosis and Institutionalization ofMentally III Patients 
Evidence suggests that disparities in treatment between the races exist 
in the case of mental illness as well as diseases of the body. At the 
outset, several studies demonstrate that racial bias may affect the 
evaluation and diagnosis of mental illness.54 In one study, the authors 
concluded that white therapists tended to rate their minority patients as 
more psychologically impaired than did African American therapists.55 
Another study suggested that therapists were more likely to conclude that 
minority patients diagnosed with psychotic or affective disorders were 
experiencing a chronic syndrome as opposed to an acute episode.56 Yet 
another study found that therapists were more likely to misdiagnose 
African American and Hispanic patients as suffering from schizophrenia 
than white patients.57 
Once the treating psychiatrist has arrived at a diagnosis, some 
investigators have suggested that the race of the patient affects both the 
decision as to type of treatment and the long-term outcomes of such 
treatment. At the outset of treatment, psychiatrists assess whether the 
patient can be treated as an out-patient or needs institutionalization. 58 
From 1960 to 1986, the ratio of minority to white patients under 
psychiatric care (per 100,000 in the population) remained the same, but 
54. See, e.g., Jay C. Wade, Institutional Racism: An Analysis ofthe Mental Health 
System, 63 AM. J. ORTHOPSYCHIATRY 536,541 (1993) (describing the results of various 
studies); K. Jenkins-Hall & William P. Sacco, Effect of Client Race and Depression on 
Evaluations By White Therapists, 10 J. Soc. & CLINICAL PSYCHOL. 322 (1991); Thomas 
W. Pavkov et aI., Psychiatric Diagnosis and Racial Bias, 20 PROF. PSYCHOL.: REs. & 
PRAC. 364 (1989); Sukdeb Mukherjee et al., Misdiagnosis of Schizophrenia in Bipolar 
Patiellfs: A Multietlmic Comparison, 140 AM. J. PSYCHIATRY 1571 (1983). 
55. See Enrico E. Jones, Psychotherapists' Impressions ofTreatment Outcome as 
a Function of Race, 38 J. CLINICAL PSYCHOL. 722 (1982). 
56. See Wade, supra note 54, at 541. 
57. See id. at 541. This disproportionate rate might be explained, in part, as 
foIJows: 
The emphasis given to one item of information as opposed to another or the 
meaning attached to an incident is dependent on the beliefs, value judgments, 
and knowledge of the psychiatrist. If the clinician fails to take into account 
environmental circumstances, he or she may misjudge normal behavior as 
pathological. 
Id. at 540-41. 
53. See id. at 537 (describing the deinstitutionalization movement that began in 
1955 and that resulted in a reduction in the number of state and county mental hospitals 
and a concurrent increase in private psychiatric hospitals and community mental health 
centers). 
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the number of minority inpatient admissions rose substantially compared 
with white inpatient admissions.59 At the same time, although the 
number of outpatient facilities increased substantially, minority patients 
receiving treatment at these facilities did not increase in a corresponding 
fashion.60 Finally, state and county hospitals function primarily to 
provide long-term care for patients for whom community-based 
outpatient services have been ineffective, and they continue to have the 
highest rates of minority patient admissions.61 
One commentator theorizes that institutional racism contributes 
substantially to these trends.62 Although some of the differences in 
rates of public hospital institutionalization result from disparities in 
income between white and African American patients, the studies 
evaluating the assessment and diagnosis process suggest that unconscious 
racial biases might play a role as well. On the one hand, the decision 
to institutionalize a patient relates directly to the clinician's diagnosis 
and projected course for the patient's treatment. The studies described 
above suggest that a patient's race may subtly impact the clinician's 
diagnosis or decision about the appropriateness of a particular therapy. 
On the other hand, once the practitioner decides to place a patient in an 
institution for inpatient care, the patient's income and insurance status 
begin to play a role in directing that patient either to a public hospital 
or a private facility. The latter problem could be addressed by 
increasing insurance coverage for mental health services and redoubling 
efforts to build outpatient clinics in inner-city and rural areas, but 
addressing racial bias at the assessment and diagnosis level seems to 
present a more intractable difficulty. 
59. See id. at 538 (noting that admissions for psychiatric care in general hospitals 
rose 37% for minority patients and only 17% for white patients, and that admissions to 
private hospitals rose 81 % for minority patients and only 46% for white patients). 
60. See id. (noting that, from 1969 to 1986, there was a 52% increase in the 
utilization of outpatient psychiatric clinics by white patients, but only a 36% increase in 
minority-race patient care at these facilities). 
61. See id. at 538-39 (noting that state and county mental hospitals admit minority 
patients at the rate of 90 per 100,000 in the general population, whereas the admission 
rate for white patients is just 30 per 100,000). 
62. See id. at 537, 539 (describing the "insensitivity to cultural and language 
differences and ... lack of interest on the part of major decision makers" that led to 
inadequate development of community mental health facilities to serve minorities, and 
noting the lack of mental health curricula designed to prepare clinicians to meet the 
"psychosocial" needs of minorities). 
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E. Minority Patient Populations in Clinical Trials 
Certain clinical research practices play a role in perpetuating racial 
(and gender) inequities in health care. For instance, new drug trials and 
other types of biomedical research frequently fail to include subjects 
from minority groups. The desire to streamline such research in order 
to produce results that are clearly and easily interpretable has led 
investigators to prefer homogenous patient populations for virtually all 
studies. Before the National Institutes of Health (Nlli) issued a directive 
in 1990, investigators almost uniformly tested new chemical entities only 
on white male subjects, excluding women and members of other 
races.63 The 1990 policy requires that applicants for clinical research 
grants either include women and minorities in their studies or provide a 
"clear and compelling rationale" for failing to include these groupS.64 
The NIH mandate finally recognized that using a homogenous research 
population provides little therapeutic benefit for persons outside that 
population after a treatment becomes generally available. The Food and 
Drug Administration (FDA) also has addressed the issue, through 
modifications of product approval guidelines that apply whether or not 
the clinical trials received some NIH funding,65 and more recently in 
63. Such studies frequently exclude children as well. Only 42% of drugs that are 
routinely used to treat pediatric patients have been tested on children in clinical trials. 
A new FDA regulation, issued in August 1997, will attempt to increase the clinical trial 
testing of drugs on pediatric patients where it is practical to do so. See Robert Pear, 
President to Order Drug Makers to Conduct Pediatric Studies, N.Y. TIMEs, Aug. 13, 
1997, at A17; see also 62 Fed. Reg. 43,900 (1997) (to be codified at 21 C.F.R. pts. 201, 
312, 314, 601) (requiring manufacturers of drugs that are widely used in pediatric 
populations but that do not contain adequate labeling information for these populations 
to submit evidence, in certain circumstances, to support dosage and administration 
directions for these patients). 
64. See Policy for Inclusion of Women and Minorities in Clinical Research Study 
Populations, available at National Institutes for Health Site (visited Mar. 10, 1998) 
<http://www.nih.gov/niams/grants.sdrc.www.htm#III.D> . 
65. See 60 Fed. Reg. 46,794 (1995) (to be codified at 21 C.F.R. pts. 312, 314) 
(proposing rule that would require manufacturers seeking new drug approval to submit 
safety and efficacy data reflecting breakdown according to gender, age, and racial 
subgroups (in addition to aggregate data), but that would not require inclusion of these 
groups in clinical trials); 58 Fed. Reg. 39,406, 39,408 (1993) (summarizing a guideline 
that concludes that the exclusion of women from early clinical trials is not medically 
necessary because the risk of fetal exposure can be minimized by patient behavior and 
laboratory testing); see also Lars Noah, Constraints on the Off-Label Uses of 
Prescription Drug Products, 16 J. PROD. & TaXIeS LIAB. 139, 139-47 (1994) (describing 
the prevalence of off-label prescribing by physicians, necessitated by limitations in 
clinical testing, and the FDA's regulatory responses). 
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its reform bill.66 
Although researchers offer a number of possibly valid reasons for 
excluding women from clinical studies (including concerns aboot harm 
to fertile women who may become pregnant, and complications posed 
by the female hormonal cycle),67 no such justifications exist for 
excluding African Americans and other minorities from biomedical 
research populations. On the contrary, scientific research has document­
ed the wide variation of the pharmacokinetic effects of drugs across 
racial and ethnic lines.68 One cannot, therefore, safely extrapolate from 
data based on white males to others in the population.69 In fact, the 
risks to women and minorities who make an informed choice to 
participate in closely monitored and controlled research are more 
justifiable than the greater risks associated with the use of approved 
drugs or treatments, untested in these populations, on a widespread basis 
after testing and FDA approval. Furthermore, diseases that affect a 
66. See 143 Congo Rec. HlO,452-56 (daily ed. Nov. 9, 1997) (House statement on 
S. 830 § 115(b». The proposal would amend the Food, Drug, and Cosmetic Act, 21 
U.S.C. § 355(b)(1), to read as follows: "The Secretary shall, in consultation with the 
Director of the National Institutes of Health and with representatives of the drug 
manufacturing industry, review and develop guidance, as appropriate, on the inclusion 
of women and minorities in clinical trials ...." 
67. See Joan W. Scott, How Did the Male Become the Normative Standard for 
Clinical Drug Trials?, 48 FOOD & DRUG L.J. 187, 187-88 (1993) (describing two 
contradictory assumptions-that women are identical to men so that female participation 
in drug trials is unnecessary, and that women are so unlike men that female participation 
in drug trials would destroy the purity of the experiment-that have contributed to this 
phenomenon). 
68. See, e.g., Craig K. Svensson, Representation ofAmerican Blacks in Clinical 
Trials of New Drugs, 261 JAMA 263 (1989) (concluding that investigators do not 
adequately account for racial differences as a source for variability in drug research 
results, and that insufficient data exist to assess the safety and efficacy for the African 
American popUlation of many drugs currently on the market); Paul Cotton, Is There Still 
Too Much Extrapolation From Data on Middle-Aged White Men?, 263 JAMA 1049 
(1990) (same); Hong-Hao Zhou et al., Racial Differences in Drug Response, 320 NEW 
ENG. J. MED. 565 (1989) (concluding that Chinese men have greater sensitivity than 
white men to the effects of the drug propanolol on heart rate and blood pressure); The 
1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment 
ofHigh Blood Pressure, 144 ARCHIVES INTERNAL MED. 1045, 1054 (1985) (noting that, 
although African Americans suffer from a higher incidence of hypertension, ACE 
inhibitors are less effective in treating this condition in African Americans than in the 
white population). 
69. See Rebecca Dresser, Wanted: Single, White Male for Medical Research, 
HASTINGS CrR. REp., Jan./Feb. 1992, at 24, 26 (describing a study in which the 
"normal" dosage of lithium for white males was found to be frequently toxic for African 
American patients). 
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disproportionate number of women or minorities historically have 
received low research funding priority.70 Some critics have suggested 
that decisions to exclude women and minorities from biomedical 
research reflect an assumption that white males most deserve the benefits 
that this research produces.71 To the extent that the Nlli and FDA 
policies do not mandate some diversification in research populations, it 
is important that investigators alter their protocols to reflect these 
concerns. 
F. Summary 
The number of published articles on medical topics utilizing categories 
of race and ethnicity or referring to patterns of "racism" has risen 
dramatically in recent years.72 But epidemiologists, concerned about 
the use of race and ethnicity as variables in health surveillance, have 
lamented the fact that "no clear consensus exists regarding the measure­
ment and use of these concepts.,,73 Participants in a recent workshop 
on these issues sponsored by the Centers for Disease Control and 
Prevention (CDC) emphasized the importance of supplementing racial 
and ethnic information with data on socioeconomic and cultural variables 
whenever relevant.74 Any attempt to remedy disparities in the delivery 
of health care services must confront the possibility of racism as a 
motivating factor in treatment decisions. Some commentators have 
concluded that the health care system as well as many of its individual 
providers perpetuate racist attitudes?5 An editorial accompanying the 
70. See id. 
71. See id. at 27-28. 
72. See Trevor A. Sheldon & Hilda Parker, Race and Ethnicity in Health Research, 
14 1. PUB. HEALTH MED. 104, 106 tbI.1 (1992). The authors used a search of Medline 
from 1985 to 1990 to illustrate their point. In 1985, a total of 879 publications 
mentioned "race" in their titles or abstracts, and only one article referred to "racism." 
By 1990, these numbers had risen to 1372 and 20 respectively. 
73. See Reuben C. Warren et al., Editorial, The Use of Race and Ethnicity in 
Public Health Surveillance, 109 PUB. HEALTH REp. 4 (1994). 
74. See id. at 5; see also Lisa C. Ikemoto, The Fuzzy Logic of Race and Gender 
ill the Mismeasure ofAsian American Womell's Health Needs, 65 U. CIN. L. REv. 799, 
807-09 (1997) (arguing that using white males as the standard by which to compare the 
health of women and minority groups perpetuates the tendency to view the health of 
white male groups as primary and to disregard the social and economic implications of 
the statistics attributed to the female and minority groups). 
75. See VerneIIia R. Randall, Slavery, Segregation and Racism: Trusting the 
Health Care System Aill't Always Easy!, 15 ST. LOUIS U. PUB. L. REv. 191,231 (1996). 
Professor Randall concludes that the disparate care received by African American 
patients constitutes a more explicit and avoidable kind of racism: "Eurocentric bioethical 
principles such as autonomy, beneficence, and informed consent .... leave considerable 
room for individual judgment by health care practitioners. . .. In a racist society (such 
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HCFA study considered the complexities inherent in formulating a 
response by the medical community to the evident racial inequities in the 
delivery of health care services. Dr. Jack Geiger, of the City University 
of New York Medical School, concluded that the "investigators tend to 
invoke unspecified cultural differences, undocumented patient preferenc­
es, or a lack of information about the need for care as reasons for the 
differences. The alternative explanation is racism-that is, racially 
discriminatory rationing by physicians and health care institutions.,,76 
Because of the complex nature of health care decisionmaking, 
however, attributing disparities in health care to racism may not 
accurately portray the whole of the problem. Racist attitudes undoubted­
ly exist at the level of the individual provider, in some cases, and certain 
institutional policies may have a disparate impact on minorities as well. 
But other contributing factors, such as the overall health status of the 
patient, the stage of disease at which treatment is sought, patient income, 
and insurance status, inevitably complicate the picture.77 Thus, 
disparities in a pattern of treatment for similar conditions depending on 
the race of the patient may result from factors other than racism.78 
Certainly such disparities may provide evidence of conscious or 
unconscious racism within the health care system, but as Professor 
Randall Kennedy recently has pointed out, "disparity" and "dis crimina­
as ours), the judgment is often exercised in a racist manner." ld. 
76. See Geiger, supra note 10, at 816. 
77. Professor Randall acknowledges that factors in addition to race-such as 
income, insurance status, and education-affect access to health care. See Randall, 
supra note 75, at 218-19 (noting that homelessness, violence, drugs, and the inability of 
managed care to provide "culturally relevant care" all adversely affect the health status 
of African Americans). In the case of epidemiological studies using race or ethnicity as 
variables: 
Differences which are described as racial are often social in origin and reflect 
the key role of social conditions, although often the studies are too poorly 
designed to distinguish ethnic group from other confounding variables such as 
social class. 
Sheldon & Parker, supra note 72, at 106. 
78. For example, one recent study found that decisions regarding the course of care 
for terminal illness tend to follow different patterns depending on the region of the 
country in which the patient resides. According to the study, elderly patients in Miami 
and New York City are more likely to spend the final days of a terminal illness in a 
hospital intensive care unit than patients in the Western states, who were more likely to 
die at home. See George Anders, ZIP Code Is a Key to Course ofTemlinal Care, WALL 
ST. J., Oct. 15, 1997, at Bl. 
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tion" are not synonymous.79 A careful evaluation of the statistics 
providing evidence of these disparities, including an analysis of 
contributing factors apart from racism, is essential to crafting policies 
that will deal effectively with the problem. 
A variety of unconscious, and largely unprovable, factors may affect 
health care decisions for minority patients. For example, treating 
physicians may "give up" earlier on their African American patients, 
either by concluding that certain treatments will be unavailing or by 
resorting to drastic solutions for those patients who present for care late 
in the disease process. Health care providers sometimes may decide that 
simplicity or utility more readily dictates a decision to resort, for 
example, to lower limb amputation in the case of diabetic complications, 
rather than leg-sparing vascular surgery to improve circulation, or to 
pursue less aggressive, non-surgical therapies (such as medication and 
dietary changes) in the case of coronary illness among African American 
patients.so Physicians' treatment decisions may reflect unstated 
prejudices-negative or pessimistic assumptions about their African 
American patients' family support networks, dietary practices, or 
adherence to recommended post-treatment care regimens. In this sense, 
unconscious racism may be one factor that perpetuates the cycle of 
poorer health among African Americans as compared with the white 
population in this country. 
III. REsPONSES TO THE PROBLEM OF DISPARITIES IN HEALTH CARE 
In terms of health status, an enormous gulf exists between white and 
AfIican Americans. As the above examples demonstrate, this difference 
exists not just with regard to a few specified diseases, but instead spans 
a wide variety of conditions and treatment choices. The solutions 
discussed in the following sections represent some of the options that 
might prove useful in undoing the effects of racial disparities in health 
79. See RANDALL KENNEDY, RACE, CRIME, AND THE LAW 9 (1997). Professor 
Kennedy eloquently criticizes the "intellectual sloppiness" surrounding the debate about 
racism in law enforcement. His words apply equally well to the health care context: 
A proper appreciation for words is not the only casualty of the intellectual 
sloppiness that has impeded analysis of racial issues in the administration of 
criminal law. Another is the proper interpretation of statistics.... Too often 
... activists ... (along with journalistic and scholarly supporters) automatical­
ly insist, simply on the basis of observable racial disparities, that officials are 
engaged in making invidious racial discriminations. They seem unaware that 
a racial disparity is not necessarily indicative of a racial discrimination. A 
disparity is often evidence of discrimination. But one must keep in mind that 
a racial disparity may stem from causes other than disparate treatment. 
[d. (footnotes omitted). 
80. See Part ILA supra (discussing HCFA study). 
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care.81 Of course, even if it were possible to achieve perfect equity in 
health care, there is no guarantee that the races would enjoy equal health 
statuses. Equitable provision of services represents just one required 
component in the drive to improve the health of various minority patient 
populations. The formulation of appropriate health policy, particularly 
as it implicates race, represents a complex task, and no single solution 
will adequately address the various imbedded issues.82 To further 
complicate matters, the recent political and judicial condemnation of 
afftrmative action efforts83 suggests that health care policies designed 
to benefit minority groups may encounter substantial opposition.84 
This Part provides an overview of existing legal remedies that may 
address particular types of health care disparities or discriminatory 
practices, and then it explores potential approaches for preventing such 
disparities in the future. The discussion concludes that legal remedies 
will likely prove unavailing in many disparate care contexts and suggests 
that prospective approaches, such as education and governmental and 
institutional oversight, may prove more effective in reducing the 
incidence of disparate health care. 
A. Retrospective Remedies 
As the medical community and the federal government consider steps 
to prevent future racial disparities in the delivery of health care services, 
victims of existing inequities may wish to pursue legal remedies. The 
remedies currently available to individual plaintiffs offer only a limited 
81. 	 Taking a broad perspective, one commentator has observed: 
[T]here are positive, lasting steps we can take to give all Americans equity in 
health care. There are powerful forces we can use to overcome racism-an 
equitable health care system and the formation of a culture of character, a 
culture that places a high priority on personal responsibility, mutual respect, 
and community service. 
Sullivan, supra note 2, at 2674. 
82. As one group of commentators put it, "Large, complex problems do not lend 
themselves to monolithic solutions ...." Medical Technology and the Law, supra note 
29, at 1625. 
83. See, e.g., Taxman v. Bd. of Educ. of Piscataway, 91 F.3d 1547 (3d Cir. 1996), 
cert. granted, 117 S. Ct. 2506 (1997), cert. dismissed, 118 S. Ct. 595 (1997); Hopwood 
v. Texas, 78 F.3d 932 (5th Cir. 1996), cert. denied, 116 S. Ct. 2580 (1996); Alison 
Mitchell, Clinton Feels Sure-Footed on the Tightrope of Race, N.Y. TIMEs, June 16, 
1997, at BlO; Symposium, Representing Race, 95 MICH. L. REv. 723 (1997). 
84. See Velvet G. Miller & Janis L. Curtis, Health Care Reform and Race-Specific 
Policies, 18 J. HEALTH POL., POL'y & L. 747, 748 (1993). 
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and disappointing range of options. The federal government also can 
pursue several statutory remedies against offending institutions that 
receive federal funds. This section will explore statutory and constitu­
tionallitigation as a response to the problem of disparate health care for 
racial minorities, and it will suggest potential avenues for reform. 
1. Remedies Under Title VI 
Title VI of the Civil Rights Act of 196485 provides the most promis­
ing federal statutory avenue for dealing with racial discrimination in 
health care delivery. In enacting Title VI, Congress prohibited any 
entity that opts to receive federal financial assistance from discriminating 
on the basis of race in providing goods or services to the intended 
beneficiaries of the federal program.86 "Federal financial assistance" 
includes Medicare and Medicaid funds, and, because nearly every 
hospital and nursing home in the United States receives such assistance, 
Title VI applies to the majority of all health care facilities.87 Regula­
tions promulgated under Title VI include a requirement that 
federally-funded programs provide contractually-binding assurances that 
they will adhere to Title VI regulations,88 and that such programs file 
"compliance reports" with the Office of Civil Rights at IllIS document­
ing the quantity and type of services provided to minorities.89 Title VI 
has been used to contest the closing of hospitals where the decision to 
close reduces access to care for minorities.90 Plaintiffs also have used 
Title VI successfully to condemn limitations on Medicaid payments that 
were facially neutral but disproportionately impacted minority program 
beneficiaries.91 
85. Pub. L. No. 88-352, 78 Stat. 252 (codified at 42 U.S.C. §§ 2000d - 2000d-4 
(1994». 
86. See 42 U.S.C. § 2000d (1994) ("No person in the United States shall, on the 
ground of race, color, or national origin, be excluded from participation in, be denied the 
benefits of, or be subjected to discriInination under any program or activity receiving 
Federal financial assistance."). 
87. See 45 C.F.R. § 80 app. A (1996) (listing grant programs that provide other 
"federal financial assistance" triggering Title VI requirements); United States v. Baylor 
Univ. Med. Ctr., 736 F.2d 1039, 1046 (5th Cir. 1984) (noting that virtually every court 
that has considered the issue has concluded that receipt of Medicare and Medicaid funds 
constitutes federal financial assistance triggering Title VI); NAACP v. Med. Ctr., Inc., 
657 F.2d 1322, 1329 (3d Cir. 1981); see also Sidney D. Watson, Reinvigorating Title 
VI: Defending Health Care Discrimination-It Shouldn't Be So Easy, 58 FORDHAM L. 
REv. 939, 945-46 (1990). 
88. See 45 C.F.R. § 8004 (1996). 
89. See id. § 80.6(b). 
90. See, e.g., NAACP, 657 F.2d 1322; Bryan v. Koch, 627 F.2d 612 (2d Cir. 1980). 
91. See, e.g., Linton v. Comm'r of Health & Env't., 779 F. Supp. 925, 934-35 
(M.D. Tenn. 1990) (state policy liIniting number of nursing home beds available for 
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The United States Supreme Court has held that Title VI prohibits both 
intentional discrimination and disproportionate adverse impact.92 The 
statute is enforced mainly by the administrative agencies that provide t.he 
federal funding, and the regulations implementing Title VI grant to 
federal agencies the power to terminate funding to any recipient that 
violates this nondiscrimination requirement.93 The implementing 
regulations specifically state that facially neutral policies that have a 
disproportionate negative impact on racial minorities violate Title VI, 
whether or not any discriminatory intent exists.94 Administrative 
agencies have consistently concluded that Title VI and its regulations 
prohibit policies that have a disproportionate adverse impact on 
minorities.95 
When the policy in question disproportionately affects minority 
patients, and the plaintiffs can prove disparate impact,96 the burden then 
Medicaid patients violates Title VI). 
92. See Lau v. Nichols, 414 U.S. 563 (1974). "Simple justice requires that public 
funds, to which all taxpayers of all races contribute, not be spent in any fashion which 
encourages, entrenches, subsidizes, or results in racial discrimination." !d. at 569 
(quoting 110 CONGo REc. 6543 (1963) (statement of Sen. Humphrey quoting from 
President Kennedy's message to Congress, June 19, 1963)). The Court subsequently 
held that, although Title VI itself prohibits only intentional discrimination, the 
implementing regulations may redress disproportionate adverse impact claims. See 
Alexander V. Choate, 469 U.S. 287, 293 (1985). Disparate impact is defined as 
"unjustified practices that are facially neutral, yet disproportionately affect minorities." 
Amy Jurevic, Disparate Impact Under Title VI: Discrimination, By Any Other Name, 
Will Still Have the Same Impact, 15 ST. LOUIS U. PUB. L. REv. 237, 241 (1996). 
93. See 42 U.S.C. § 2000d-l (1994) (providing an opportunity for a hearing prior 
to termination of federal financial assistance based on a violation of Title VI or its 
implementing regulations). The administrative hearings are subject to judicial review 
under 42 U.S.C. § 2000d-2. 
94. See 45 C.F.R. § 80.3(b) (1996) (prohibiting activities that impair agency 
objectives with regard to race, color, or national origin, and those that result in a 
disproportionate impact on a group). 
95. See, e.g., Organ Procurement and Transplantation Network, 59 Fed. Reg. 
46,482-83 (1994) (to be codified at 42 C.F.R. pt. 121) (concluding that Title VI applies 
to organ procurement organizations and transplant hospitals that receive federal funds); 
see also Watson, supra note 87, at 948. Title VI regulations prohibit "criteria or 
methods of administration which have the effect of subjecting individuals to discrimina­
tion because of their race, color, or national origin, or have the effect of defeating or 
substantially impairing accomplishment of the objectives of the program as respect 
individuals of a particular race, color, or national origin." 45 C.F.R. § 80.3(b )(1)(vii)(2). 
96. See Stan Dom et al., Anti-Discrimination Provisions and Health Care Access, 
20 CLEARINGHOUSE REv. 439, 441 & n.27 (1986) (describing the use of "test­
ers"-people pretending to be patients, who share common traits or symptoms except 
for their race-to prove that patients of a particular race receive different treatment). 
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shifts to the defendant to justify the policy. In a case challenging the 
closure of a municipal hospital under Title VI,97 the United States 
Court of Appeals for the Second Circuit required only that the policy be 
rationally related to a legitimate need.98 In another case, a different 
court held that once the plaintiffs made out a prima facie case of 
discrimination, the defendant recipient of federal funds must demonstrate 
that its policy or decision was rational and that the decisionmaking 
process was lawfu1.99 The court held that the usual deference accorded 
to agency decisionmaking was not required where the state agency was 
a defendant in a discrimination case. 100 
In the hospital context, a variety of facially neutral policies may have 
a disproportionate impact on racial and ethnic minorities seeking 
treatment. Examples include practices such as admitting only patients 
who have treating physicians with staff privileges at the hospital, 
requiring substantial deposits before admission for inpatient care, 
refusing to deliver babies if their mothers have not received a specified 
amount of prenatal care, and creating barriers to the admission of 
Medicaid patients. 101 Many minority patients do not regularly receive 
care from a physician with hospital privileges, many of these patients do 
not have the financial resources to pay a deposit for care, many minority 
women do not receive adequate prenatal care, and minorities comprise 
a large percentage of Medicaid patients. 102 Each of these policies can 
97. See Bryan v. Koch, 627 F.2d 612 (2d Cir. 1980) 
98. See id. at 617-19 (implicitly applying this standard). The plaintiffs argued for 
a higher standard, requesting that ilie court determine whether the hospital closing was 
"necessary to achieve legitimate objectives" and that the court uphold the closing only 
if the city's objectives could not be accomplished by other means that had a less 
disproportionate adverse effect on the plaintiffs. See id. at 618; see also NAACP v. 
Med. Ctr., Inc., 657 F.2d 1322, 1336 (3rd Cir. 1981) (requiring that a hospital relocation 
serve a legitimate bona fide interest, and suggesting a rational relationship test to 
evaluate the defendants' justification under Title VI). 
99. See Jennings v. Alexander, 715 F.2d 1036, 1044 (6th Cir. 1983), rev'd sub 
nOIll. Alexander v. Choate, 469 U.S. 287 (1985). The plaintiffs challenged the state's 
Medicaid policy that limited the number of inpatient hospital days per year covered by 
Medicaid, arguing that such a policy would deter handicapped Medicaid recipients from 
using hospital services early in the year. See id. at 1042-44. The case was filed under 
section 504 of the Rehabilitation Act, but its disparate impact analysis has been 
interpreted as analogous to that for Title VI cases because its statutory language is 
virtually identical. See id. at 1040-41; see also Jurevic, supra note 92, at 246. 
100. See Jennings, 715 F.2d at 1044. 
101. See Watson, supra note 87, at 941-42; see also Dom et al., supra note 96, at 
441 (describing other examples of such policies, including not having physicians on staff 
who accept Medicaid patients and refusal to participate in programs to finance care for 
low-income patients who do not qualify for Medicaid). 
102. See Watson, supra note 87, at 941 nn.15-18. One commentator has argued that 
the Oregon Medicaid List of Prioritized Health Services, which ranks diseases and their 
treatments in order of importance, is subject to challenge under Title VI. The Medicaid 
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be justified based on concerns about cost-limitation or liability; yet each 
policy also excludes a disproportionate number of minority patients from 
obtaining the hospital care they need. Title VI provides one avenue for 
attacking these "subtle barriers" to care.103 
Even so, Title VI only prohibits those inequities that arise from the 
application of facially neqtral policies-it does not prohibit racial 
inequities whenever they occur. Thus, the difficulty lies with pinpoint­
ing the policy creating the disproportionate impact. HCFA could argue, 
on the basis of recent statistics, that discriminatory criteria in the health 
care decisionmaking process impede the Medicare program's goal of 
providing consistent, high quality care to all beneficiaries. HCFA will 
find it difficult, however, to identify precisely which policies are causing 
the disproportionate impact. Similarly, the individualized medical 
decisionmaking that occurs in the contexts of mental illness diagnosis 
and drug prescribing is unlikely to result from institutional mandates or 
policies, facially neutral or otherwise; thus HCFA will find such 
decisions difficult to challenge under Title VI. In contrast, federal 
agencies can more readily identify policies causing disparate racial 
impact in the allocation of kidneys for transplantation and in protocols 
for clinical research, making these types of medical decisions more 
readily subject to challenge when a pattern of disparities emerges. 
Thus, administrative enforcement of Title VI fails to address or 
capture the effects of actions of individual physicians who deliver care 
at institutions that are required to comply with the statute. Physicians 
with staff privileges at hospitals and nursing homes who deliver care in 
a discriminatory manner, either consciously or unconsciously, presum­
ably are not adhering to any formal institutional policy. In such a 
situation, the agency will find it difficult to lay blame at door the of the 
institution and revoke its federal funding. A standard holding the 
provider institution responsible for its staff physicians' discriminatory 
conduct when the institution knows or has reason to know that a 
physician was providing care in a discriminatory manner might represent 
a partial response to this problem. Ultimately, however, this solution is 
funds available cover services ranked up to approximately #600, and fail to cover 
treatments for obesity. Since 48% of African American women are clinically obese, 
compared with 32% of white women, and since obesity increases the risk for a variety 
of other serious diseases, the failure to cover obesity treatment disproportionately 
burdens African American women. See Jurevic, supra note 92, at 253-55. 
103. See Watson, supra note 87, at 941. 
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unsatisfactory, because it does not directly address the problem of the 
hidden, unconscious racist assumptions that sometimes affect health care 
decisions. As long as physicians can offer alternative explanations for 
treatment decisions, conduct of this sort appears to be out of the reach 
of legal remedies. 
Individual litigation under Title VI offers less promise. In Guardians 
Association v. Civil Service Commission,104 the Supreme Court held 
that a private right of action under Title VI exists only in certain limited 
circumstances.105 In a private suit, the plaintiff may secure equitable 
relief if able to prove intentional discrimination. The Court did not, 
however, clearly answer the question of whether similar relief might be 
available where the plaintiff can only prove the disparate impact of a 
facially neutral policy.!06 In one earlier case, the Supreme Court held 
unanimously that a school district's facially neutral policy violated Title 
VI. 107 The Court has since cited this decision for the proposition that 
Title VI prohibits policies that create a disproportionate adverse impact 
on minorities, although the justices were not unanimous in reaching this 
more general conclusion. 108 In a more recent decision, the Court 
interpreted Guardians Association to hold that Title VI itself prohibits 
only intentional discrimination, although it also noted that the regulations 
implementing Title VI provide a basis for a disparate impact claim. 109 
Even so, one commentator has suggested that private plaintiffs "can 
prevail upon a showing of disproportionate adverse impact without proof 
of intent to discriminate as long as they are careful to allege a violation 
of the Title VI regulations."llo 
104. 463 U.S. 582 (1983). 
105. See id. at 593-95 (plurality opinion). Victims of racial discrimination cannot, 
of course, seek termination of federal financial assistance to the offending institution, but 
can sue to recover damages and equitable relief. Victims may also file an administrative 
complaint with the Office of Civil Rights at the Department of Health and Human 
Services. See 45 C.F.R. § 80.7(b) (1996). 
106. See Guardians, 463 U.S. at 642-45; see also 1 RODNEY A. SMOLLA, FEDERAL 
CIVIL RIGHTS ACTS 8-9 to 8-10 (3d ed. 1994). 
107. See Lau v. Nichols, 414 U.S. 563 (1974). 
108. The majority opinion in Lau, to which five justices subscribed, relied on the 
language of the statute's implementing regulations that expressly prohibits practices that 
have a discriminatory effect, and imputed the express prohibition in the regulations to 
the statute itself. See id. at 566-68. Other justices concluded instead that the regulations 
were the product of valid administrative action. See id. at 570-71 (Stewart, Burger, & 
Blackmun, U., concurring); see also Watson, supra note 87, at 949-50 (discussing Lau). 
109. See Alexander v. Choate, 469 U.S. 287, 293-94 (1985). 
110. Watson, supra note 87, at 953. Professor Watson noted that the question of 
what relief Title VI plaintiffs can obtain remains unsettled, as do issues surrounding 
evidentiary burdens. See id. at 954. 
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Even if private plaintiffs need not establish discriminatory intent, a 
disparate impact claim may remain difficult to establish. Lower courts 
faced primarily with challenges to hospital closings and relocations have 
utilized a rational basis test, which makes defending Title VI discrimina­
tion claims relatively easy for health care entities; courts have upheld 
such actions even where plaintiffs have suggested less discriminatory 
alternatives.11l As in cases brought by the government, the lack of 
rigorous scrutiny in Title VI litigation creates significant barriers to 
challenging policies that have a disproportionate impact on minorities. 
Plaintiffs will prevail under this standard only if they can prove that the 
challenged policies are arbitrary and fail to advance any legitimate 
purpose. 
One commentator has suggested strengthening the standard of review 
for Title VI challenges; under the proposed approach, the defendant 
would have to demonstrate that the challenged policy "significantly" 
furthers an important purpose, and courts would give more consideration 
to the availability of less discriminatory alternatives as proof that the 
interests behind the challenged policy are insufficient to justify its 
disparate racial impact. 112 Unless the courts accept such an approach, 
however, administrative agencies will shoulder most of the responsibility 
for enforcing Title VI in the health care arena. To date, they have not 
done so. 
2. Equal Protection Theories 
In addition to statutory rights of action, patients who have suffered 
disparate treatment based on their race might consider an equal 
111. See NAACP v. Med. Ctr., Inc., 657 F.2d 1322, 1333-34, 1366-67 (3d Cir. 
1981) (noting that, even if plaintiffs had presented a prima facie case of disparate 
impact, defendants need only present evidence of an acceptable reason and are not 
required to show absence of discriminatory motive); Bryan v. Koch, 627 F.2d 612, 
617-19 (2d Cir. 1980) (holding that Title VI does not require a federal fund recipient to 
consider alternatives to the closing of a public health facility if the criteria used to make 
the decision are reasonably related to a goal such as cost savings). One judge in Bryan 
urged the court to engage in a two-pronged evaluation of the agency action, flrst 
examining the process by which the decision was reached and then inquiring into the 
substantive merits of the decision. See id. at 623 (Kearse, J., concurring in part and 
dissenting in part). 
112. See Watson, supra note 87, at 976; see also Jurevic, supra note 92, at 264 
(proposing that, once the plaintiff makes a prima facie case of disparate impact, the 
impact must be sufficiently justifled). 
163 
protection challenge. In its current formulation, however, equal 
protection analysis may not provide a workable remedy for disparities 
in health care delivery. First, plaintiffs will find it difficult to demon­
strate the necessary "state action" if their complaint centers around the 
decision of a provider not to pursue a particular course of treatment. In 
many of the contexts presented above-Medicare services, kidney 
allocation, access to prescription drugs, institutionalization for mental 
illness, and clinical trials-plaintiffs will find it difficult to prove state 
action. 113 The receipt of federal funding triggers statutory obligations 
but does not necessarily constitute state action. 114 
Second, plaintiffs cannot easily prove discriminatory intent, particular­
ly in the contexts of organ allocation and decisions to utilize particular 
medical treatments. A host of "confounding variables" including, 
perhaps, unconscious racial stereotyping, makes the intent of the medical 
decisionmaking difficult to discern. Health care providers making 
individualized medical decisions concerning, for example, whether to 
utilize a sophisticated coronary procedure for one patient or whether to 
prescribe a dose of antibiotics for another, can always offer a medical 
justification for their decision, even if the decision in fact arose from a 
conscious or unconscious reaction to the patient's race. Those involved 
in the organ allocation process likewise can explain in medical terms 
why a particular patient is not a good candidate for a transplant (and 
thus should not be wait-listed), although the medical explanation may 
113. One group of commentators has speculated that, in the organ transplantation 
context, the UNOS allocation policies constitute state action for purposes of requiring 
due process because the contract between the privately-run corporation and the federal 
government arguably creates an adequate nexus. See Medical Technology and the Law, 
supra note 29, at 1638 (suggesting that the relationship between UNOS, OPTN, and the 
federal government might make UNOS a de facto state actor). The authors concluded, 
however, that the recent trend in state action cases, together with the enormous burden 
that due process requirements would impose on the organ allocation process, makes it 
highly unlikely that the Supreme Court would deem UNOS a state actor. See id. at 
1640. 
114. See, e.g., Blum v. Yaretsky, 457 U.S. 991, 1011-12 (1982) (finding no state 
action by nursing home even though the bulk of its activities were financed by state 
Medicaid program); see also Rendell-Baker v. Kohn, 457 U.S. 830, 840-41 (1982) 
(finding no state action by a private school even though the bulk of its funding was 
received from the state); Moose Lodge No. 107 v. Irvis, 407 U.S. 163, 166-67 (1972) 
(holding that pervasive regulation of an activity does not by itself constitute state action). 
Similarly, claims based on a denial of due process under the Fifth and Fourteenth 
Amendments will also likely fail for want of state action. See, e.g., White v. Moses 
Taylor Hosp., 763 F. Supp. 776, 785-86 (M.D. Pa. 1991) (concluding that a hospital's 
receipt of funds under the Hill-Burton Act does not constitute state action); see also 
Loh-Seng Yo v. Cibola Gen. Hosp., Inc., 706 F.2d 306, 308 (10th Cir. 1983); Modaber 
v. Culpepper Mem'l Hosp., 674 F.2d 1023, 1026 (4th Cir. 1982); Newsom v. Vanderbilt 
Univ., 653 F.2d 1100, 1115 (6th Cir. 1981); Hodge v. Paoli Mem'} Hosp., 576 F.2d 563, 
564 (3d Cir. 1978). 
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include psychosocial factors as well.115 If a plaintiff cannot prove that 
the institutional provider intended to discriminate, courts will simply 
examine whether a rational basis exists to justify its actions, rather than 
review the actions under a strict scrutiny standard. 116 
Thus, as with private statutory rights of action under Title VI, 
constitutional challenges seem unavailing. No matter how compelling 
the evidence of racial inequities in the health care context, nothing 
convincingly suggests a pattern of widespread intentional discrimination. 
Clearly, discrimination can exist without proof of invidious intent, but 
not all documented inequities across racial lines constitute discrimina­
tion.117 "Intent" in the equal protection context embodies ideas of 
willfulness and morally reprehensible motivation. Even so, disparate 
health treatment decisions that do not result from poor preventive care, 
or from a patient's presenting with a more acute condition, may well 
arise from unconsciously biased decisions on the part of health care 
professionals. Given these complexities, it seems appropriate to 
reconsider the current equal protection analysis requirement that 
plaintiffs prove intentional discrimination. 118 
115. See, e.g., Medical Technology and the Law, supra note 29, at 1636 ("[FJactors 
that are admittedly relevant in determining whether a particular patient will be [a] good 
transplant recipient, such as occupation, educationalleve1, and family environment, might 
be used as yardsticks of social worth or means by which unconscious stereotypes 
influence patient selection."). 
116. See, e.g., Washington v. Davis, 426 U.S. 229, 244-45 (1976) (holding that 
plaintiff was required to prove discriminatory intent); United States v. Yonkers Bd. of 
Educ., 837 F.2d 1181, 1216 (2d Cir. 1987) ("[T]o prove a claim of discrimination in 
violation of the Equal Protection Clause a plaintiff must show not only that the state 
action complained of had a disproportionate or discriminatory impact but also that the 
defendant acted with the intent to discriminate."). 
117. Cf. McCleskey v. Kemp, 481 U.S. 279 (1987) (rejecting constitutional 
challenge to death penalty notwithstanding convincing statistical evidence of racial 
disparities in capital sentencing). 
118. For a critique of the "false dichotomy" between disproportionate impact and 
intentional discrimination, see Charles R. Lawrence, III, The /d, the Ego, and Equal 
Protection: Reckoning with Unconscious Racism, 39 STAN. L. REv. 317, 321-23 (1987). 
Professor Lawrence argued that the required proof of discriminatory intent for an equal 
protection claim ignores the pervasiveness and the profound impact of unconscious 
discrimination, and he proposed a new test that would evaluate governmental conduct 
"to determine whether it conveys a symbolic message to which the culture attaches racial 
significance," in which case strict scrutiny would apply. See id. at 324. Professor 
Lawrence's test would not, however, apply strict scrutiny in those cases "where 
nonrace-dependent decisions ... disproportionately burden blacks only because they are 
overrepresented or underrepresented among the decision's targets or beneficiaries." [d. 
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3. Other Statutory Remedies 
Other statutes relating to the provision of health services also may 
provide avenues for addressing disparities in access to certain types of 
health care. When Congress initially enacted the Hill-Burton Act,119 it 
sought to provide federal funding for hospital construction. The Act 
provides a limited means of redress for patients against hospitals that 
implement discriminatory admissions policies. Under the Act, all 
facilities receiving these funds must provide "a reasonable volume of 
services to persons unable to pay" except if "such a requirement is not 
feasible from a financial viewpoint.,,120 The Act's "community service 
obligation" also requires Hill-Burton facilities to furnish health care 
services in a non-discriminatory fashion. 121 The original Act required 
participating hospitals to ensure that their facilities were available to all 
persons residing in the hospital's territorial area without discrimination 
based on race, creed, or color, but this provision was later amended to 
require simply that facilities be available to all residing within the 
territorial area of the hospital receiving Hill-Burton funds. 122 
The Act does not grant individual patients a private right of action to 
demand medical treatment, but it does permit individual suits to compel 
enforcement of the Act's uncompensated care and community service 
provisions by the offending hospital. 123 Several cases interpreting the 
119. Ch. 958, 60 Stat. 1041 (1946) (codified as amended at 42 U.S.C. § 291 
(1994». 
120. See 42 U.S.C. § 291c(e)(2) (1994). 
121. See, e.g., Metro. Med. Ctr. v. Harris, 693 F.2d 775, 787 (8th Cir. 1982) (noting 
that regulations implementing the Hill-Burton Act allow recipients of these federal funds 
to limit the availability of their services under the community service obligation only 
based on age, medical indigency, or type or kind of medical or mental disability, and 
that the statute and the regulations clearly suggest that Hill-Burton fund recipients refrain 
from "engaging in discriminatory admission practices"); Lugo v. Simon, 426 F. Supp. 
28, 36 (N.D. Ohio 1976) (noting that a regulation placing a 20-year limit on the statute's 
service requirement appears to be plainly inconsistent with the statutory language and 
is therefore impermissible). 
122. See 42 U.S.C. § 291c(e)(i) (1990); see also Simkins v. Moses H. Cone Mem'l 
Hosp., 323 F.2d 959 (4th Cir. 1963) (striking down an exception to the community 
service obligation that permitted "separate but equal" facilities); Metro. Med. Ctr., 693 
F.2d at 787. Implementing regulations elaborate on the anti-discrimination requirement. 
See 42 C.F.R. § 124.603(a), (d) (1996) (providing that Hill-Burton facilities may not 
discriminate based on "race, color, national origin, creed, or any other ground unrelated 
to an individual's need for the service" and may not utilize admissions policies that have 
the effect of excluding persons on impermissible grounds). 
123. See 42 U.S.C. § 300s-6 (1991); 42 C.F.R. § 124.606(a)(4); Wey v. Evangelical 
Community Hosp., 833 F. Supp. 453, 461-62, 465 (M.D. Pa. 1993) (holding that a 
private individual may act as a "private attorney general" by bringing an action to ensure 
compliance with the provisions of the Hill-Burton Act, but finding no facts to support 
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Act have concluded, however, that individual private actions under the 
Act are limited to this enforcement role only and that the Act and its 
implementing regulations do not support suits for personal relief. 124 
Thus, although an individual who is subjected to discriminatory 
admissions policies at a Hill-Burton hospital can file a private action to 
compel the hospital's compliance with statutory obligations, such a right 
of action appears more of a symbolic victory than a practical means of 
remedying the wrong. 
Another statute provides limited remedies for victims of discriminatory 
or otherwise unequal access to emergency hospital care. The provisions 
of the Emergency Medical Treatment and Labor Act (EMTALA)I25 
apply to all hospitals that receive federal Medicare funds and that have 
emergency departments or provide emergency medical care. Under the 
provisions ofEMTALA, participating hospitals must screen every patient 
seeking emergency room services,126 and, if the patient has an emer­
gency medical condition,127 they must stabilize the patient before 
any violation in the case). 
124. See White v. Moses Taylor Hosp., 763 F. Supp. 776, 783 (M.D. Pa. 1991) 
(holding that an individual may bring a private action under the Hill-Burton Act to 
effectuate a funds-recipient's compliance with the Act but is restricted to enforcing the 
hospital's compliance with its "assurances" and may not seek personal relief); see also 
42 U.S.C. § 300s-6 ("An action to effect compliance with any such assurances may be 
brought by a person other than the Secretary ...."); 42 C.F.R. § 124.511(a)(4) ("[TJhe 
person filing it may bring a private action to effectuate compliance with the assurance."). 
125. Pub. L. No. 99-272, § 9121(b), 100 Stat. 164 (1986) (codified as amended at 
42 U.S.C. § 1395dd (1994)). This Act is frequently referred to as "COBRA" because 
it was passed as part of this budget reconciliation act, or as the "Anti-Dumping Act" 
because it prohibits patient dumping. 
126. See 42 U.S.C. § 1395dd(a) (1994) (requiring "an appropriate medical screening 
examination within the capability of the hospital's emergency department, including 
ancillary services routinely available to the emergency department, to determine whether 
or not an emergency medical condition ... exists"). 
127. See id. § 1395dd(e)(I). This section defines an "emergency medical condition" 
as: 
a medical condition manifesting itself by acute symptoms of sufficient severity 
(including severe pain) such that the absence of immediate medical attention 
could reasonably be expected to result in­
(i) placing the health of the individual (or, with respect to a pregnant 
woman, the health of the woman or her unborn child) in serious jeopardy, 
(ii) serious impainnent to bodily functions, or 
(iii) serious dysfunction of any bodily organ or part .... 
Id. The next paragraph of the statute includes labor in the definition of an emergency 
medical condition requiring treatment. See id. § 1395dd(e)(I)(B). 
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transferring him or her.128 Any individual who is harmed as a "direct 
result" of the hospital's violation of the statute has a private right of 
action against the hospital. 129 Some courts have suggested that the 
hospital's or the treating physician's motive in transferring the patient 
may be relevant in proving that the hospital violated the Act, by failing 
either to provide an appropriate screening and stabilizing treatment or to 
properly determine that the benefits outweighed the risks of transfer.130 
In one recent case, the United States Court of Appeals for the Sixth 
Circuit found no evidence of a violation of EMTALA based on the facts 
of the case,131 but in dicta it included a detailed discussion about 
reasons other than indigency for denying appropriate care that might 
constitute a violation of the statute: 
These might include: prejudice against the race, sex, or ethnic group of the 
patient; distaste for the patient's condition (e.g., AIDS patients); personal dislike 
or antagonism between the medical personnel and the patient; disapproval of the 
patient's occupation; or political or cultural opposition. If a hospital refused 
treatment to persons for any of these reasons, or gave cursory treatment, the evil 
inflicted would be quite akin to that discussed by Congress in the legislative 
history, and the patient would fall squarely within the statutory language.132 
Thus, it appears that the Sixth Circuit would be willing to impose 
liability for disparate treatment under the "appropriate medical screen­
ing" provision of EMTALA as long as the plaintiff can prove a bad 
motive on the hospital's part. In contrast, the United States Court of 
Appeals for the D.C. Circuit evidently would impose statutory liability 
for disparate treatment regardless of the hospital's motives.133 Finding 
no violation of the "appropriate medical screening" requirement, the 
court noted that "any departure from standard screening procedures 
128. See id. § 1395dd(e)(3)(B) (providing that an individual is "stabilized" if "no 
material deterioration of the condition is likely, within reasonable medical probability" 
during or resulting from the individual's transfer). The statute defines stabilization of 
a woman having labor contractions as delivery. See id. 
129. See id. § 1395dd(d)(2)(A). 
130. EMTALA permits transfer of non-stable patients in situations where the 
treating physician certifies that "the medical benefits reasonably expected from the 
provision of appropriate medical treatment at another medical facility outweigh the 
increased risks to the individual." Id. § 1395dd( c) (1)(ii). 
131. See Cleland v. Bronson Health Care Group, Inc., 917 F.2d 266,271 (6th Cir. 
1990). 
132. Id. at 272. The Fifth Circuit has cited Cleland with approval. See Burditt v. 
HHS, 934 F.2d 1362, 1370 n.8 (5th Cir. 1991) ("One may prove that a hospital has 
violated this standard by presenting evidence that something other than the present or 
projected medical needs of its patients detennined the treatment provided."). 
133. See Gatewood v. Wash. Healthcare Corp., 933 F.2d 1037, 1041 (D.C. Cir. 
1991). 
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would constitute an inappropriate screening in violation of [the 
Act].,,134 
The remedies provisions of EMTAL.t\ are limited in scope. Plaintiffs 
suing under the "appropriate medical screening" theory can seek 
damages or equitable remedies from the hospital providing (or failing to 
provide) treatment.135 The statute also establishes civil monetary 
penalties against the hospital and the "responsible" physician for 
violations of the Act.136 Of course, remedies available under 
EMTALA only concern access to emergency medical care and leave 
many of the examples of disparate care described above unresolved. 
B. Prospective Solutions 
The following sections suggest several initiatives that, taken together, 
might begin to improve communication and to close the gap in 
utilization of health care treatments and services and, eventually, in the 
relative health statuses of white and minority patients. Education about 
the problem of racial disparities in health care delivery will likely be 
more effective than either litigation or regulation at changing the 
attitudes of institutional and particularly individual health care provid­
ers.137 Because patient-specific treatment choices are the least amena­
134. Id. at 1041. The court acknowledged its departure from the reasoning in 
Cleland regarding the way "motives" relate to the issue, and added that "[t]he motive 
for such departure is not important to this analysis, which applies whenever and for 
whatever reason a patient is denied the same level of care provided others and 
guaranteed him or her by subsection 1395dd(a)." ld. at 1041, 1041 n.3. 
135. See 42 U.S.C. § 1395dd(D)(2)(A) (1994) (pennitting civil actions against 
hospitals for damages for personal injury and "such equitable relief as is appropriate"). 
Courts have, however, rejected suits against individual physicians and physician groups 
under the Act. See, e.g., Delaney v. Cade, 986 F.2d 387, 393-94 (10th Cir. 1993) 
(holding that the plain language of the statute indicates that individuals can bring civil 
suits only against hospitals, and not against individual physicians); Baber v. Hosp. Corp. 
of Am., 977 F.2d 872, 876-78 (4th Cir. 1992) (holding that the statutory language did 
not pennit individuals to recover personal injury damages from a doctor based on 
violations of the Act). 
136. See 42 U.S.C. § 1395dd(d)(I)(A), (B) (setting out penalties against hospitals 
of not more than $50,000 (or not more than $25,000 for hospitals with fewer than 100 
beds) for each violation of the Act, and a penalty of not more than $50,000 against 
individual physicians for each violation). 
137. See Miller & Curtis, supra note 84, at 750-51 (discussing the potential negative 
consequences of race-specific health reform policies, such as stigmatization of the 
benefitting group, implying that such groups are homogenous and thus interfering with 
individualized patient care, and generally "fuel[ing] the flames of racial divisiveness," 
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ble to scrutiny under statutory or constitutional standards, the following 
proposed approaches deserve serious consideration from the federal 
government and the medical community. 
1. Medical Education 
Evidence suggests that most patient complaints arise from communica­
tion problems with physiciansYs In addition to affecting patients' 
perceptions about the care that they receive, communication significantly 
impacts patient adherence to prescribed medical regimens, such as 
medication and diet. 139 Because patient non-compliance with physician 
recommendations can contribute to undesirable therapeutic out­
comes,140 many medical schools are adding a communication skills 
component to their curriculum, either at the medical college or graduate 
medical education stage.141 Medical schools in the United States 
commonly offer a course or part of a course dealing with the 
physician-patient relationship. Most programs cover the subject as part 
of an existing required course, though others offer it as a stand-alone 
required or elective course. 142 
and concluding that such mandates are ineffective at changing attitudes towards race 
issues). 
138. See Tessa Richards, Chasms in Conununication: Physician-Patient Commullica­
tion, 301 BRIT. MED. J. 1407, 1407-08 (1990). 
139. See Judith A. Hall et aI., Meta-Analysis ofCo"elates ofProvider Behavior in 
Medical Encounters, 26 MED. CARE 657, 666 (1988). Although the study did not focus 
on race, the study noted a trend suggesting that white patients receive more detailed 
information during consultation with providers than do African American patients. See 
id. at 667; see also Daniel E. Shapiro et al., The Effect of Varied Physician Affect on 
Recall, Anxiety, and Perceptions in Women at Risk for Breast Cancer, 11 HEALTH 
PSYCHOL. 61, 61-66 (1992). 
140. See John Hornberger et al., Bridging Language and Cultural Barriers Between 
Physicians and Patients, 112 PUB. HEALTH REp. 410, 410-11, 416 (1997) (''When a 
physician and patient do not share a common language or culture, communication 
difficulties may compromise the patient's care, potentially resulting in worse health 
outcomes, especially among patients with complex or chronic medical problems."). 
141. See Stephen R. Boggs et aI., Development and Evaluation of a Communica­
tions Skills Training Program for Resident Physicians (1996) (unpublished manuscript, 
on file with author). 
142. See ASSOCIATION AM. MED. COLLEGES, 1996-1997 CURRICULUM DIRECTORY 
12 tbl.6 (indicating that 108 medical schools cover the physician-patient relationship as 
part of a required course, another 23 programs offer the course as a required separate 
course, and 23 offer the course as an elective); see also Mary Anne C. Johnston, A 
Model Program to Address Insensitive Behaviors Towards Medical Students, 67 ACAD. 
MED. 236, 236-37 (1992) (describing a program at the University ofPennsylvania School 
ofMedicine designed to educate students and faculty members about insensitive behavior 
towards minority groups, women, and gays and lesbians, and noting that medical schools 
wishing to graduate sensitive and caring physicians can begin the process by addressing 
instances of disrespectful behavior that arise during the medical education program). 
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It is difficult to determine the content of such courses. In some 
medical schools, the "Introduction to Clinical Medicine" or equivalent 
course includes topics such as patient-interviewing and communication, 
as well as discussions about the interrelationship between race, gender, 
poverty, and health.143 Along the same lines, Dr. Geiger, in his 
response to the HCFA study findings, urged medical schools to train 
students about issues surrounding race and health care, including the 
development of courses designed to increase sensitivity and improve 
understanding of diverse ethnic groupS.I44 In addition, practicing 
physicians can educate their peers about these issues through continuing 
medical education programs. 
As a corollary to such curricular responses, Congress must retain its 
commitment to encouraging the training of minority health care 
professionals.145 Health care scholars and ethicists have argued that 
143. See Elysa Gordon, Note, Multiculturalism in Medical Decisionmaking: The 
Notion of Infonned Waiver, 23 FORDHAM URB. L.J. 1321, 1355 & n.193 (1996) (also 
describing other suggested approaches for improving cross-cultural communication in the 
healthcare context). 
144. See Geiger, supra note 10, at 816. Dr. Geiger also suggested that physicians 
confront the following questions: 
What choices are black patients and white patients actually offered by their 
physicians? What do they hear? Do their physicians make specific recom­
mendations? Do the patients participate fully in the decision-making process? 
What criteria do physicians use in making these clinical judgments? Are they 
applied equitably, or are they subtly influenced by racial stereotyping on the 
part of time-pressured physicians, reinforced both by institutional attitudes and 
by unwarranted assumptions about prevalences and outcomes? 
/d.; see also Gordon, supra note 143, at 1355 (suggesting practice guidelines and 
incentives that "encourage physicians to approach patients about their cultural values"). 
145. See Sullivan, supra note 2, at 2674. One set of programs, created under the 
Disadvantaged Minority Health Improvement Act of 1990, Pub. L. No. 101-527, 104 
Stat. 2311 (codified in scattered sections of 42 U.S.C.), instituted a series of 
federally-funded grants and loan programs aimed at increasing the numbers of minority 
students enrolled in health professions schools. The Act provides grants to "centers of 
excellence" at medical and dental schools with the goals of establishing programs to 
enhance the academic performance of minority students, increasing the numbers of 
minority students in the programs, improving program recruiting and retention of 
minority faculty, and facilitating research on health issues affecting minority groups. See 
42 U.S.C. §§ 2541, 295g-2 (1994). The Act also established grants for scholarships and 
loan repayment programs to support minority health professions students. See id. 
§§ 2541,2541-1. The Health Resources and Services Administration recently announced 
that it will award $13.5 million in funding awards for programs in medicine, dentistry, 
and pharmacy at historically black colleges, including Florida A&M University, 
Morehouse School of Medicine, and Texas Southern University. See HRSA News 
(visited Feb. 7, 1998) <http://www.hrsa.dhhs.govlNews-PAlhbcumill.htm>. 
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the minority patient population's lack of trust in the predominately-white 
medical system discourages these patients from seeking early medical 
attention, even when such care is accessible. 146 Encouraging minorities 
to enter the health care professions in greater numbers may help to 
create a culture of trust between the health care system and its minority 
patients. 
2. Professional Awareness and Institutional Responses 
In addition to the possibility of individualized prejudices,147 uncon­
scious racism may appear at an institutional level as well. 148 In this 
era of cost-consciousness, hospitals and insurers have created complex 
guidelines to limit the care that patients receive. 149 For example, an 
insurance plan that refuses reimbursement for an elective procedure if 
the patient previously has received less than optimal management of his 
or her disease may negatively impact minority patients, who tend to have 
less overall access to care. Although such guidelines certainly are not 
race-based, they may tend to perpetuate the prevalence of certain 
conditions among minority patients. As noted above, a variety of factors 
other than unconscious discrimination contribute to this problem: for 
whatever reason, African Americans tend to make fewer visits to 
physicians for ambulatory care than white patients, and they often 
present for initial care at later stages of disease than white patients. Low 
incomes appear to exacerbate these problems, 150 but the HCFA study 
146. See Randall, supra note 75, at 191-92 ("[F]ear and distrust of the health care 
system is a natural and logical response to the history of experimentation and abuse .... 
That perspective keeps African Americans from getting health care treatment . . .."). 
Health policy specialists, physicians, and even corporations are beginning to respond to 
the problems created by this fear and distrust of the health care system. The Wrigley 
Corporation and Health Watch, a health advocacy group, recently joined together to 
produce an advertising campaign designed to encourage African Americans and other 
minorities to visit doctors for preventive care, and to seek early detection and control of 
disease. See Wrigley Ads to Focus on Minority Health, WALL ST. J., June 4, 1997, at 
BI. 
147. Many people who have learned racist attitudes as children may decide to 
discard these attitudes as adults, but they may not succeed in keeping unconscious 
attitudes from affecting their decisionmaking. See Edward P. Boyle, Note, It's Not Easy 
Bein' Green: The Psychology of Racism, Environmental Discrimination, and the 
Argument for Modernizing Equal Protection Analysis, 46 VAND. L. REv. 937, 939 
(1993). 
143. See id. ("Institutional racism occurs when the group in power structures its 
social institutions so as to maintain its dominance over other groups."). 
149. See, e.g., Barbara A. NOM, The Managed Care Dilemma: Can Theories of 
Tort Liability Adapt to the Realities of Cost Containment?, 48 MERCER L. REv. 1219, 
1225-29 (1997) (describing a variety of managed care cost-containment strategies). 
150. See Gornick et aI., supra note 7, at 793-94 (noting that in 1993 African 
American Medicare beneficiaries made 7.2 visits per person to physicians for ambulatory 
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demonstrated that differences in income alone do not account for the 
observed disparities in health care delivery. Institutional policies may 
reflect unconscious biasesQr, at the very least, a lack of concern about 
existing disparities. 
Both physicians and health care institutions ultimately will bear the 
bulk of the responsibility for detecting and responding to patterns of 
disparate treatment. The forces of peer pressure, perhaps reinforced by 
the threat of regulatory action against the hospital,151 can provide a 
powerful incentive for individual and institutional self-monitoring. At 
the institutional level, hospitals might incorporate into their quality 
assurance protocols an ongoing evaluation and monitoring of racial 
disparities in the provision of services.152 
To this end, hospitals could create an anonymous reporting mechanism 
to help detect and respond to instances or patterns of discriminatory 
decisionmaking. In addition, periodic discussion among administrators, 
physicians, hospital ethics staff, and other relevant employees would 
serve to raise awareness of, and increase sensitivity to, racial and cultural 
issues. One commentator has proposed the creation of interdisciplinary 
care teams, comprised of social workers, nurses, psychiatrists, and 
patient advocates. The commentator observed that "[t]hese disciplines 
have historically considered the impact of individuals' cultural identity 
in their theory and practice and patients may perceive these professionals 
as more closely aligned with their interests than physicians . . .."153 
Another possible approach would incorporate racial and cultural 
considerations into the physician-patient dialogue by directly questioning 
patients about their treatment-related concerns, their views about medical 
decisionmaking, and relevant religious or ethical values.154 Finally, 
care compared with 8.1 visits per person among white patients). 
151. See supra Part ill.A.3. 
152. See Geiger, supra note 10, at 816; see also AMA Council on Ethical & 
Judicial Affairs, Black-White Disparities in Health Care, 263 JAMA 2344, 2346 (1990) 
(proposing the development and use of practice parameters including criteria designed 
to diminish racial disparities). 
153. See Gordon, supra note 143, at 1356 (footnote omitted). 
154. See Robert D. Orr et al., Cross-Cultural Considerations in Clinical Ethics 
Consultations, 4 ARCHIVES FAM. MED. 159, 163 (1995). Orr and his co-authors also 
suggest that providers: (1) avoid making assumptions about the patient's cultural or 
ethnic background; (2) consult with health care practitioners who share the same ethnic 
background as the patient; (3) avoid stereotyping patients based on their race or the 
language that they speak; (4) use non-family translators where possible; (5) be aware of 
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some HMOs and medical malpractice insurers now offer cultural 
sensitivity training to their physicians in an effort to improve communi­
cation and overall quality of care.155 
3. Regulatory Vigilance 
Regulatory agencies also can play a role in focusing attention on the 
problem of racial inequalities in the health care system. The Joint 
Commission on Accreditation of Healthcare Organizations (JCAHO) 
might insist upon organizational self-monitoring and correction of 
unexplained disparities in the delivery of health services as a condition 
of continued accreditation for hospitals and other provider organiza­
tions.156 In addition, HCFA might in the future require more careful 
utilization review methods designed to identify and correct any observed 
patterns of racial inequities in the delivery of services to Medicare and 
Medicaid recipients. 
Similarly, UNOS, which already has demonstrated an awareness of 
these issues in organ allocation, will no doubt continue to gather 
information and shape its allocation policies in a manner that promotes 
sensitivity to race issues among the many players in the transplantation 
process. The UNOS Committee on Minority Affairs regularly monitors 
and evaluates the impact of race on access to transplantation at all 
personal biases and prejudices; and (6) be sensitive to the provider's powerful influence 
over the patient and family during the decisionmaking process. See id; see also Ben A. 
Rich, The Values History: A New Standard of Care, 40 EMORY L.J. 1109, 1141-43, 
1147-52 (1991) (advocating the use of a "values history"-an oral or written questioning 
of the patient-in order to (1) understand the patient's views about the type and degree 
of medical intervention that the patient would want should the patient's competency be 
compromised, and also to (2) facilitate the patient's autonomous decisionmaking by 
providing the physician and other caregivers with an understanding of the patient's 
wishes, fears, ethical values, and/or spiritual beliefs). 
155. See George Anders, Doctors Learn to Bridge Cultural Gaps, WALL ST. J., 
Sept. 4, 1997, at Bl (describing how one large California HMO has a cultural 
anthropologist on staff to assist in the development of special health programs for 
minority members, and describing an independent organization that provides 
"cross-cultural workshops" for HMO clients and other healthcare providers). 
156. Cj. Timothy Stoltzfus Jost, Medicare and the loint Commission on Accredita­
tion of HealthCare Organizations: A Healthy Relationship?, 57 LAW & CONTEMP. 
PROBS. 15, 38 (1994) ("The Joint Commission has often played a leading role in 
encouraging progressive change in the health care industry. Examples of recent 
reform-motivated additions to Joint Commission accreditation standards include 
requirements that hospitals institute policies to improve communication with non-English 
speaking patients .... "). See generally Timothy Stoltzfus Jost, The loint Commission 
on Accreditation of Hospitals: Private Regulation of Health Care and the Public 
Interest, 24 B.C. L. REv. 835 (1983) (describing JCAHO accreditation processes); James 
S. Roberts et aI., A History of the loint Commission on Accreditation ofHospitals, 258 
JAMA 936 (1987). 
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stages, on registration at the transplantation center, on the allocation 
process, and on the ultimate success rates of each type of procedure. 
In the areas of access to prescription drug therapy and diagnosis and 
treatment of mental illness, government agencies will find it more 
difficult to identify institutional policies or consistent patterns that could 
become targets for reform. To the extent that AIDS clinics receive 
federal funding and demonstrate a pattern of disparate prescribing of 
AIDS therapies, HCFA might respond with a requirement of more 
careful utilization monitoring to detect race-based inequities in care, and 
then require prompt responses to such inequities as a condition of 
continued funding. Addressing disparate prescribing patterns such as 
those in the pediatric prescription drug study described above may prove 
impossible at the governmental level. Such decisions are too much 
within the ambit of physician discretion, and probably rightly so, to be 
captured and reformed by a regulatory initiative. Even so, the govern­
ment may decide to encourage additional study of these issues, perhaps 
by providing grants for appropriately designed research. 
By carefully monitoring compliance with its 1990 directive, Nlli can 
reduce or eliminate underrepresentation of minorities and women in 
clinical trials. Clinical investigators and pharmaceutical manufacturers 
also can playa greater role in combating this problem. One commenta­
tor has proposed several ways of improving scientific understanding of 
the varying drug responses among patients of different racial and ethnic 
backgrounds.157 Clinical investigators, and also the journal editors 
who publish the results of these trials, should include data on the racial 
composition of the study group whenever possible. In addition, 
pharmaceutical manufacturers, in the course of developing new drugs, 
should attempt to increase the enrollment of African Americans and 
other minorities in clinical trials, particularly when the drugs in question 
are intended to treat conditions that affect a disproportionately large 
percentage of minority patients. ISS 
4. Other Governmental Initiatives 
The federal government can reaffirm its commitment to ending 
disparate health care treatment for minorities in the United States in 
157. See Svensson, supra note 68, at 265. 
158. See id. 
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other ways. In 1994, President Clinton issued an Executive Order 
regarding federal action to promote environmental justice for minority 
and low-income populations.159 The Order created an interagency 
working group on environmental justice designed to provide guidance to 
federal agencies "for identifying disproportionately high and adverse 
human health or environmental effects on minority populations ...."160 
The Order charged the group with developing environmental justice 
strategies, coordinating research, and collecting data to address the 
disparate effects of federal environmental policy on minorities. 161 A 
similar Executive Order creating an interagency working group to 
address racial issues in the provision of health care could provide the 
coordination of governmental agency activity needed to respond to 
existing disparities on a broad scale. 
Such a working group could perform several useful functions. First, 
it could monitor and track existing disparities by compiling and 
analyzing data from a variety of sources. HCFA obviously would be 
asked to provide data on utilization rates for Medicare and Medicaid 
services (as in the study discussed above, but on a broader and more 
regular basis). Other agencies, such as Nlli, CDC, UNOS, and the FDA 
also might supply relevant data. 162 Second, the working group could 
use this data to develop strategies for both agencies and provider 
institutions to address any identified racial disparities. 163 The working 
159. See Exec. Order No. 12,898, 59 Fed. Reg. 7629 (1994). Interesting parallels 
exist between health care discrimination and recent scholarship suggesting constitutional 
approaches to what has been characterized as "environmental racism." For example, 
recent articles have suggested that "environmental racism" impacts decisions such as the 
siting of toxic dumps and cleanup efforts, but the articles nevertheless conclude that 
equal protection analysis is unlikely to assist those seeking to claim unlawful 
discrimination in these contexts. See, e.g., Naikang Tsao, Ameliorating Environmental 
Racism: A Citizen'S Guide to Combatting The Discriminatory Siting of Toxic Waste 
Dumps, 67 N.Y.U. L. REv. 366, 406-07 (1992); Boyle, supra note 147, at 979-80; cf. 
Lynn E. Blais, Environmental Racism Reconsidered, 75 N.C. L. REv. 75, 132, 142 
(1996) (noting that most environmental equity activists do not allege that siting decisions 
are made based on invidious criteria but rather result from the disproportionate impact 
of facially neutral policies, and suggesting that existing disproportionate impacts result 
from inequalities of wealth). 
160. Exec. Order No. 12,898, § 1-102(b), 59 Fed. Reg. at 7629. 
161. See id. 
162. The working group should provide minority populations with the opportunity 
to comment on the development of research strategies designed to analyze the issue of 
how race affects the provision of health care. 
163. Such an Executive Order might mandate that each federal agency responsible 
for health related issues conduct all activities that affect human health "in a manner that 
ensures that such programs, policies, and activities do not have the effect of excluding 
persons (including populations) from participation in, denying persons (including popula­
tions) the benefits of, or subjecting persons (including populations) to discrimination 
under such programs, policies, and activities because of their race, color, or national 
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group would seek to accomplish several goals including provider 
education and sensitization to issues of race in health care, as well as 
improving outreach and education for minority communities to increase 
the utilization of preventive care and early detection of disease. 
Although race is difficult to isolate from factors like insurance status and 
income that also affect the provision of health care, the working group's 
direct confrontation of the role that race plays would represent an 
important step toward improving health care for those whose access to 
care currently is inadequate. 
IV. CONCLUSION 
Socioeconomic factors explain only a portion of the racial disparities 
that exist in health care delivery. Recognition of these disparities, 
whatever their source, demands a swift response. The medical and legal 
communities must begin to address race-based variations in treatment, 
such as differences in the rates at which certain medical procedures are 
performed, allocation policies that create racial disparities in the rates of 
organ transplantation, access to prescription drug therapy, the diagnosis 
and treatment of mental illness, and the failure to include historically 
underrepresented groups in clinical research. 
Existing legal remedies will provide little recourse to the victims of 
these disparities. Until changes in the relevant statutory and constitu­
tional standards permit a judicial response, the medical community and 
governmental agencies must confront the problem at its source, by 
educating and regulating health care providers as well as others who 
control the medical decisionmaking process. Mechanisms already exist 
to identify and reduce racial disparities in the delivery of health care 
services, but there has not been a full appreciation of the extent of this 
problem. More research-controlling for critical variables such as race, 
income levels, insurance coverage, severity of disease, and pre-existing 
health conditions-will help to clarify the nature and extent of these 
disparities, and the role that conscious or unconscious racial bias may 
play in perpetuating them. Meanwhile, it is important to implement a 
variety of approaches to deal with the existing racial inequalities, 
whatever their source. At the same time, members of the medical 
community and state and federal governments should carefully examine 
origin." Exec. Order No. 12,898, § 2-2, 59 Fed. Reg. at 7630. 
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their motivations in making treatment decisions and in designing health 
policy. Although perfect equity in the provision of health services does 
not guarantee equality of health status among the races, it constitutes an 
important step towards better health for all Americans. 
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